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ABSTRACT OF DISSERTATION

THE METASTASIS SUPPRESSOR NM23-H1 IS REQUIRED FOR DNA REPAIR
NM23-H1 represents the first identified metastasis suppressor, exhibiting
reduced expression in breast carcinoma and melanoma, and an ability to inhibit
metastatic growth without significant impact on the transformed phenotype.
Although its molecular mechanism of action is not fully understood, NM23-H1
possesses at least three enzymatic activities that may mediate metastasis
suppressor function. It catalyzes nucleoside diphosphate kinase (NDPK) activity,
as well as protein histidine kinase and 3’-5’ exonuclease activities. As 3’-5’
exonucleases are generally required for maintenance of genomic integrity, this
activity represents a plausible mediator to underlie the metastasis suppressor
function of NM23-H1 protein. To investigate the relevant activity of NM23-H1 in
metastasis suppression, we constructed a panel of NM23-H1 mutant variants with
selective enzymatic lesions. Previous studies have identified some key amino
acid residues important for the enzymatic characteristics of NM23-H1. However,
none of them are selective for disrupting the 3’-5’ exonuclease activity. In this
study, we show that a substitution of Glu5 to alanine results in a dramatic,
selective loss in 3’-5’ exonuclease property without significant affecting other
enzymatic activities. To measure the extent to which the exonuclease function
opposes mutation and metastasis, NM23-deficient and metastatic cell lines with
forced expression of NM23-H1 variants are analyzed in nude mice. In
spontaneous metastasis models, NM23-H1 mutants deficient in 3‘-5’ exonuclease
activity significantly disrupt the capacity of metastasis suppression of wild-type
protein, indicating that the 3’-5’ exonuclease activity of NM23-H1 is necessary for
the spontaneous metastasis-suppressing effects. As 3'-5' exonucleases are
generally associated with DNA repair process, we have also studied the
contributions of yeast NM23 homologue YNK1 to genomic integrity in
Saccharomyces cerevisiae. Consistent with an antimutator function, ablation of
YNK1 significantly results in increased mutation rates following exposure to UV
irradiation and the alkylating agent methyl methanesulfonate (MMS). The
impaired DNA-damage response of ynk1∆ cells suggests a role of human
homologue NM23 in DNA repair. More evidence is being collected in our
laboratory to demonstrate a role for NM23-H1 in maintaining genomic integrity.
Collectively, our findings of DNA repair activity of NM23-H1 will contribute to the

understandings of the mechanisms in metastasis suppression and new drug
discoveries.
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CHAPTER ONE
INTRODUCTION

1.1.

Cancer Metastasis Progression and Genomic Instability
Tumor metastases arise from the spread of cancer cells from a primary

site and form the colonization in distant organs. Most invasive, malignant
tumors give rise to tumor metastases by a multi-step process as shown in
Figure 1, in which primary cells lose cellular adhesion, increase motility,
invade surrounding tissues, disseminate through the bloodstream to distant
organs, and proliferate in new locations (Chambers et al., 2002). Each step
must be successfully completed to give rise to a metastatic tumor. Tumor
metastases, instead of primary tumors, are the cause of 90% of human
cancer deaths (Sporn, 1996). To prevent these deaths, better understanding
of the processes and mechanisms of tumor invasion and metastasis is
essential to identify promising molecular targets for cancer therapy.
Metastasis is an inefficient process, by which millions of cells might be
released by a tumor into the circulation, but only a tiny minority of these cells
will colonize at a distant organ (Siclari et al., 2006). In vivo microscopy and
cell-fate analysis have showed that some steps (e.g., invasion and metastatic
colonization) of the metastatic process are more inefficient than some other
steps (e.g., cells survival in the circulation, arrest in a distant organ and initial
extravasation) (Chambers et al., 2002). Metastatic inefficiency is primarily due
to the regulation of cancer cell growth in secondary sites. However, due to
their genetic instability and heterogeneity, tumors do have a distinct chance to
overcome incompatible microenvironments. During tumor progression, many
genes gain or lose function allowing a cancer cell to acquire the prerequisites
for metastasis such as altered cell adhesion, limitless replication, increased
motility and invasion, and anchorage independent growth (Nguyen and
Massague, 2007).
Progression of cancer from a less malignant to a more malignant
phenotype is well-accepted to be due to inherent genomic instability (Loeb,
1991, 2001). The accumulated genetic and epigenetic changes lead to an
increasingly aggressive and treatment-resistant phenotype, and ultimately
1

metastasis. This idea is supported by evidence that highly metastatic clones
from tumor-cell populations had higher mutation rates than non-metastatic
clones from the same tumor. For example, spontaneous mutation rates to
ouabain resistance measured in six human melanoma cell lines by Luria and
Delbrück using fluctuation analysis correlated with the metastatic ability of the
cells: moderately and highly metastatic cells showed spontaneous mutation
rates 10 to 50 times higher than those of poorly metastatic cells (Bailly et al.,
1993). These results provided a direct link between metastasis and genetic
instability.
.

2

Figure 1. Metastasis is a complex, multistep process.

Picture from 2003 Nature Reviews Cancer 3, 55 - 63
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1.2. NM23 is a Metastasis Suppressor
Metastasis suppressors, by definition, repress metastasis without
affecting primary tumor growth. The concept of tumor suppressor prompted
the identification of metastasis suppressors, which were found to exhibit
reduced expression in highly metastatic tumors or cell lines compared to that
of non-metastatic tumor cells (Steeg, 2003). Some other metastasis
suppressor genes were cloned when chromosomes or portions of
chromosomes were transfected into cell lines and a decrease in metastatic
potential was observed. So far, thirteen metastasis suppressor genes have
been confirmed (Palmieri et al., 2006). The entire panel of metastasis
suppressor genes were validated by re-expression in a metastatic cell line,
resulting in inhibition of in vivo metastasis without significant effect on
tumorigenicity as compared to controls (Steeg, 2003).
Metastasis suppressors often affect many aspects of signal transduction
pathways including invasion, growth-factor-receptor signaling, the mitogenactivated protein kinase pathway, cell-cell communication and transcription
(Steeg, 2003). For instance, KAI1, a metastasis-suppressor for prostate and
breast carcinomas (Dong et al., 1996; Yang et al., 1997), belonging to a
tetraspanin family of transmembrane proteins, is directly associated with the
EGF receptor and attenuates EGF-induced migration signaling (Odintsova et
al., 2000).
cancer,

MKK4, another metastasis-suppressor for prostate and ovary

transduced

signals

from MEKK1 to

stress-activated protein

kinase/JNK1 and p38 mitogen-activated protein kinase (Kauffman et al., 2003;
Teng et al., 1997). By this mitogen-activated protein kinase pathway, MKK4
regulated the signal transduction of stress-induced apoptosis in cancer (Kim
et al., 2001; Yamada et al., 2002).
nm23, the first identified metastasis suppressor gene, represents the
most widely validated metastasis suppressor gene based on transfection and
knockout mouse strategies. Transfection of nm23-H1 or -H2 cDNAs (or their
murine homologues -M1 or -M2) into some metastatically competent cell lines
can reduce in vivo metastatic potential of these cell lines without significant
effects on primary tumor formation (Palmieri et al., 2006). These observations
were further supported by studies performed in nm23-M1 knockout mice:
4

when hepatocellular carcinoma was induced into the knockout mice, primary
tumor size did not change significantly, whereas the incidence of metastases
increased markedly (Boissan et al., 2005). A correlation has been established
between low NM23 expression and high metastatic potential in multiple
cancers, e.g., melanoma, hepatoma, breast and gastric carcinoma (Hartsough
and Steeg, 2000). However, this correlation was absent or opposite in other
cancers (e.g., colon carcinoma; (Myeroff and Markowitz, 1993) ), suggesting
NM23 may play different roles in different tissues.
So far, nine human NM23 members (named as NM23-H1 to -H9) have
been reported and were found in multiple subcellular compartments (Lacombe
et al., 2000; Sadek et al., 2003). The two most abundantly expressed and the
most widely studied, NM23-H1 and NM23-H2, are 88% identical in amino acid
sequence. They encode the A and B isoforms of nucleoside diphosphate
kinase (NDPK) respectively, catalyzing the transfer of a γ-phosphate between
NTPs and NDPs via a “ping-pong” mechanism (Agarwal et al., 1978). The
NM23/NDPK genes are highly conserved from prokaryotes to eukaryotes. In
addition to NDPK activity, many other biochemical and biological functions
were attributed to NM23 proteins, including histidine protein kinase activity
(Freije et al., 1997), DNA cleavage activity (Ma et al., 2004; Postel, 1999),
transcriptional regulation (Ma et al., 2002; Postel, 2003), and protein binding
interactions (Salerno et al., 2003).
Finally, it has been reported that NM23/NDPK families play an important
role not only in tumor metastasis but also in cell growth, differentiation,
development and apoptosis (Lombardi et al., 2000). However, despite
extensive studies, the whole picture of NM23 relating to its multiple functions
is still under way. Our lab focuses on the study of the anti-metastatic
mechanisms of NM23-H1.

1.3. Enzymatic Activities and the Potential Anti-metastatic Mechanism(s)
of NM23
NM23 proteins have been identified to possess multiple enzymatic
activities, but the biological and biochemical mechanism(s) underlying its
5

ability to suppress metastasis still remain under active investigation. Figure 2
summarizes the primary biochemical activities of NM23-H1 as understood at
present, and highlights potential anti-metastatic functions for each.

6

Figure 2. Potential anti-metastatic functions of the primary enzymatic
activities of NM23-H1.

Picture from 2006 J. Bioenerg. Biomembr. 38:163 -167
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1.3.1. Nucleoside diphosphate kinase (NDPK) activity
NM23 proteins have been characterized as nucleoside diphosphate
kinases (NDPK) (Lascu et al., 2000), although not all members in the NM23
family exhibited NDPK activity (in human, only recombinant H1, H2 and H4
contained NDPK activity; (Yoon et al., 2005)). NDPK is a ubiquitous enzyme
highly

conserved

from

bacteria

to

human,

which

catalyzes

the

phosphorylation of nucleoside diphosphates to nucleoside triphosphates using
ATP as phosphor-donor via a “ping-pong” mechanism (Agarwal et al., 1978).
The ping-pong mechanism involves a conserved histidine as the intermediate
where the imidazole side chain gets auto-phosphorylated.

In addition, NDPK is a highly efficient enzyme with a turnover number of about
103 s−1 and a kcat/Km of about 107 M−1 s−1, and utilizes either purine or
pyrimidine ribo- or deoxyribonucleosides as substrates (Postel, 1998). As
highly efficient phospho-transferases, NDPKs maintain an intracellular
nucleotide balance for nucleic acid synthesis and other metabolic functions.
However, the gene encoding NDPK is not essential for viability in E. coli and
yeast (Fukuchi et al., 1993; Lu et al., 1995). Mutants of E. coli lacking ndk
exhibited normal growth rates but showed a mutator phenotype that was
attributed to the absence of NDPK catalytic activity or to an imbalance in
cellular nucleotide triphosphates (Lu et al., 1995). Although it was suggested
that the NDPK activity of NM23-H1 was not essential for suppressing the
metastatic potential (MacDonald et al., 1993), this yet needs to be
demonstrated using an in vivo forced expression model.

1.3.2. Histidine protein kinase activity
Histidine protein kinases are well described in prokaryotes and lower
eukaryotes, where they form the “two-component” signal transduction system.

8

The prototypical two-component regulator system is comprised of two proteins,
a histidine protein kinase (sensor protein), which usually binds to the cell
membrane, and a response regulator (effector protein), which is associated
with an internal response. The sensor kinase, when activated by a signal,
autophosphorylates at a histidine residue using ATP as a phosphor-donor.
Then, the phosphorylated sensor kinase transfers the phosphoryl group to a
conserved aspartate residue in the response regulator. This phosphorylation
modulates the activity of the effector protein to elicit an adaptive response to
the stimulus (Calera et al., 1998). Several features distinguish histidine protein
kinases: (1) histidine is a high energy bond; (2) phosphohistidine is acid labile,
and therefore difficult to detect in conventional gel systems; (3) histidine
kinases form a phosphohistidine intermediate, which then transfers the
phosphate to the substrate (Ouatas et al., 2003).
The histidine protein kinase activity of NM23 was reported to correlate
with motility suppression. When wild-type and site-directed mutant (P96S and
S120G) nm23-H1 constructs were transfected into MDA-MB-435 breast
carcinoma cells, the P96S mutant (histidine kinase deficient) showed impaired
motility suppression (MacDonald et al., 1996). In addition to inhibiting
metastasis in vivo and motility in vitro by overexpression of NM23-H1, a
diminished Map kinase activation was also found by Steeg and colleagues
(Hartsough et al., 2002). Kinase suppressor of Ras (KSR), a scaffold protein
for the mitogen-activated protein kinase (MAPK) cascade, was coimmunoprecipitated with NM23-H1 from both transfected 293T cells and
human

MDA-MB-435

breast

carcinoma

cells.

Autophosphorylated

recombinant NM23-H1 phosphorylated KSR in vitro and serine was
determined as the major target by phosphor-amino acid analysis. In the same
paper, they also found that Map kinase activation was reduced in an nm23-H1
transfected MDA-MB-435 cells. Moreover, the P96S-H1 transfectant exhibited
relatively high levels of activated Map kinase, suggesting that the histidine
protein kinase activity of NM23-H1 was needed for suppression of Map kinase
activation. Therefore, it was hypothesized that overexpression of NM23-H1
increased the KSR phosphorylation and inhibited Map kinase activation,
which may contribute to the mechanism of metastasis suppression
(Hartsough et al., 2002). However, the relevant downstream substrate of the
9

histidine kinase and their relationships to metastasis suppression awaits more
detailed characterization.

1.3.3. DNA binding and transcriptional regulation
NM23-H2 is recognized as the transcription factor PuF, which activates
transcription of the c-myc gene in vitro by binding to and activating a
nuclease-hypersensitive element (NHE) in the c-myc promoter (Berberich and
Postel, 1995). These in vitro findings have been confirmed in living cells (e.g.,
Burkitt lymphoma cells) by cell transfection assays (Ji et al., 1995). The NHE
contains an asymmetric pattern of repeated sequences, “GC” rich regions,
which would form unusual structures, including “slipped DNA”, loops, triplexes,
and G-quadruplex structures (Postel, 2003). In addition, NM23-H2/PuF is
capable of recognizing and interacting with such unusual structural elements
to activate the c-myc gene (Postel, 1998, 1999).
Later, NM23-H1 was identified as a DNA-binding protein to the plateletderived growth factor-A (PDGF-A) chain promoter in our laboratory (Ma et al.,
2002). The PDGF-A chain promoter is regulated by several enhancer and
silencer elements, which are GC-rich and possess non-B DNA structures.
NM23-H1 was identified to bind and mediate a silencer element in the 5’flanking sequence of the PDGF-A gene termed 5’-SHS by screening a HeLa
cell cDNA expression library with the DNA recognition site approach.
Transient transfection analyses in HepG2 cells revealed that both H1 and H2
repressed transcriptional activity driven by the PDGF-A basal promoter (-82 to
+8), another NHE element. Activity of the negative regulatory region (-1853 to
-883), which contained the 5’-SHS, was also inhibited by H1 and H2. These
studies demonstrated for the first time that NM23-H1 also interacted with DNA
structurally and functionally. They also indicated a role for both NM23 proteins
in repressing transcription of an oncogene, providing a possible molecular
mechanism to explain their metastasis-suppressing effects.

10

1.3.4. DNA cleavage activity
NM23-H2 cleaved both DNA strands of a duplex oligonucleotide
substrate comprised of the c-myc nuclease hypersensitive element (NHE),
leaving double-stranded breaks within the repeated sequence elements
(Postel, 1999). The breaks produced staggered ends with 5-nucleotide-long
3’-extensions. A covalent protein-DNA complex was suggested between the
cleaved 5’-phosphoryl ends and lysine-12 (Postel, 1999). Since covalent
protein-DNA complexes were known to serve the roles of breaking and
rejoining DNA strands, it was concluded that NM23-H2 was involved in DNA
structural transactions necessary for the activity of the c-myc promoter (Postel,
2003). Lysine-12 was identified to be the amino acid responsible for the
covalent cleavage by NM23-H2 (Postel et al., 2000). In particular, the ε-amino
group acted as the critical nucleophile, because substitution with glutamine
but not arginine completely abrogated covalent adduct formation and DNA
cleavage, whereas the DNA-binding properties remained intact (Postel et al.,
2000). These findings and chemical modification data suggested that
phosphodiester-bond

cleavage

by

NM23-H2

occurred

via

a

DNA

glycosylase/lyase-like mechanism (Postel et al., 2000), which was known as
the signature of nucleases in base excision repair (Cunningham, 1997;
McCullough et al., 1999). A DNA repair-like activity for NM23 would be
consistent with its role in suppressing the metastatic progression.
We focused our attention on the DNA cleavage activity of NM23-H1, in
which we demonstrated 3’-5' exonuclease activity by virtue of its ability in
stoichiometric amounts to excise single nucleotides in a stepwise manner
from the 3' terminus of DNA (Ma et al., 2004). The lines of evidence to support
that the 3'-5' exonuclease activity is an intrinsic ability of NM23-H1 are: 1)
precise coelution of enzymatic activity with NM23-H1 protein during
purification by hydroxylapatite and gel filtration column high performance
liquid chromatography and 2) site-specific mutation of a residue shown
previously to inactivate the NM23-H2 isoform (K12Q) also resulted in a
reproducible loss of 3’-5’ exonuclease activity in NM23-H1. The DNA-binding
and 3'-5' exonuclease activity of NM23-H1 was further confirmed by
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mutagenesis assays and NMR studies by the Pfeifer group (Yoon et al., 2005).
Generally, 3’-5’ exonucleases play critical roles in maintaining genomic
stability, and their loss often leads to increased mutation rates. Plus, antimutator functions are commonly associated with tumor suppressors.
Therefore, this raises the questions: does the 3’-5’ exonuclease activity of
NM23-H1 play a role in maintaining the genomic integrity of a cell? If so, does
this anti-mutator function mediate the metastasis suppressor activity of NM23H1? These important questions will be addressed in this project.

1.4. Project Objectives
The 3’-5’ exonuclease activity is very intriguing in light of the association
of these enzymes with DNA repair processes, and the mutator phenotypes
often arise as a consequence of their deficiencies (Shevelev and Hubscher,
2002). Progression to the metastatic phenotype is well-recognized to require
the accumulation of mutations that permit tumor cells to overcome numerous
barriers to metastatic growth. Currently, we propose that the 3’-5’
exonuclease activity of NM23-H1 plays an important role in maintaining
genomic stability and in turn suppressing metastatic progression of tumor
cells. This could be a logical candidate explanation for the anti-metastatic
mechanism of NM23-H1.
To test our hypothesis, we used site-directed mutagenesis to generate a
panel of NM23-H1 mutants in which the primary biochemical activities of the
molecule (NDPK, histidine kinase and 3’-5’ exonuclease) have been
individually inactivated. The metastasis suppressor activities of these variant
NM23-H1 mutants were further analyzed by in vivo metastasis assays, in
hopes of showing that loss of anti-metastatic function would be related to the
inactivated biochemical activity of NM23-H1 mutant. Moreover, in an effort to
quantify the contribution of NM23-H1 to its potential anti-mutator function, we
initiated experiments in the yeast Saccharomyces cerevisiae. S. cerevisiae
provides an excellent eukaryotic model for rapid and convenient analysis of
mutation rates. The budding yeast genome has been sequenced and
knockout strains are available for essentially all genes. To measure the extent
12

to which expression of YNK1 (NM23 homologue in S. cerevisiae) is required
for genomic integrity in a cell, mutation rates in ynk1∆ strain were measured
under basal conditions and genotoxic stress.
The overall goal of this project is to understand the physiological role of
the 3’-5’ exonuclease activity of NM23-H1, as well as its potential relationship
to metastasis suppressor activity.

Copyright © Mengmeng Yang 2008
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CHAPTER TWO
SITE-DIRECTED MUTAGENESIS IDENTIFIES RESIDUES NECESSARY
FOR MUTIPLE ENZYMATIC ACTIVITIES OF THE METASTASIS
SUPPRESSOR, NM23

2.1. Introduction
nm23-H1 was the first identified metastasis suppressor gene on the
basis of its reduced expression in highly metastatic melanoma and breast
carcinoma cells, and an ability of forced NM23-H1 expression to inhibit
metastatic potential without significant impact on the transformed phenotype
(Steeg et al., 1988). The human NM23 proteins are composed of six identical
subunits of 17-19 kDa each and assemble into hexamers as arrangement of
“dimer of trimers”. In x-ray crystal structure, as shown in Figure 3B, each
monomer folds into four-stranded anti-parallel β sheets surrounded by α
helices (Morera et al., 1995; Webb et al., 1995).
NM23-H1 has been discovered to exhibit multiple enzymatic activities,
but the mechanism(s) underlying its ability to suppress metastasis still remain
controversial. First, the NDP kinase activity of NM23-H1 plays an important
role in maintaining nucleotides balance; however, its relevance to metastasis
suppression is still uncertain. Second, the histidine kinase activity of NM23-H1
was reported to correlate with motility suppression. NM23-H1 mutants (e.g.
P96S and S120G) exhibited a decreased activity in histidine-dependent protein
phosphotransferase in vitro (Freije et al., 1997). Both mutants lacked the
motility-suppressing capacity of the wild-type NM23-H1 when overexpressed
in MDA-MB-435 breast carcinoma cells (MacDonald et al., 1996). However,
the in vivo downstream substrate of the histidine kinase activity of NM23 is
still not clear. The relevance of this activity to metastasis suppression needs
to be examined in an animal model. Finally, NM23-H2 was able to cleave the
internal sites within the nuclease-hypersensitive element (NHE) sequence
(Postel, 1999), which was further characterized as DNA glycosylase/lyase-like
mechanism, a hallmark of base excision DNA repair enzymes (Postel et al.,
2000). Moreover, our laboratory has recently identified that recombinant
NM23-H1 possesses significant 3’-5’ exonuclease activity in vitro (Ma et al.,
14

2004). Generally, enzymes that contain 3’-5’ exonuclease activity are involved
directly in DNA repair processes and maintenance of genomic stability
(Shevelev and Hubscher, 2002). Therefore, we hypothesized that loss of the
3’-5’ exonuclease activity of NM23-H1 during tumor progression could
possibly impair genomic integrity and increase mutation rates, thereby
enhancing the metastatic potential. However, due to the multiple impacts of
metastasis suppressor on a cell, contributions from other biochemical
pathway to metastasis suppression also need to be considered.
To study the active sites for the multiple enzymatic activities of NM23-H1,
site-directed mutagenesis was initiated in our laboratory. Previous studies in
our laboratory identified amino acid residues important for the enzymatic
characteristics of NM23-H1. For instance, lysine12 was necessary for both the
cleavage and NDP kinase activities of NM23-H1; whereas histidine118, the
NDPK catalytic site, to phenylalalnine mutation led to a total loss of NDP
kinase activity (Ma et al., 2004). However, none were selective for disrupting
the exonuclease activity. To test our hypothesis that the 3’-5’ exonuclease
activity of NM23-H1 might mediate its suppressing effects on metastasis, the
first goal was to identify a mutant selectively disrupted in the 3’-5’
exonuclease activity. Therefore, more amino acid residues were targeted to
be substituted. First, the substitution of glutamine17 to asparagine (Q17N) of
NM23-H2 identified that the necessity of residue Gln17 was only for DNA
cleavage but not NDP kinase activity (Postel et al., 2002). Since 88% of the
amino acid residues in the NM23-H1 protein are identical to NM23-H2, the
similar results were expected to be exhibited in NM23-H1 based on the same
residue substitutions. Second, the residue Glu5 was recently reported to be
critical for DNA cleavage activity of NM23-H1 (Yoon et al., 2005). To fully
understand the importance of this residue on the multiple enzymatic activities
of NM23-H1, a Glu5 to alanine mutation (E5A) was introduced as part of this
study. Third, our laboratory found the residues Tyr52 and Asp54 of NM23-H1
are homologous with the same residues on the EXOIII domain of known 3’-5’
exonucleases. The EXOIII motif has been identified as the required DNA
cleavage domain, which was highly conserved in selected 3’-5’ exonucleases
from prokaryotic to mammalian species (Shevelev and Hubscher, 2002).
Therefore, these two residues were believed to be important for the
15

exonuclease activity of NM23-H1 and needed to be tested. Finally, a Pro96 to
serine (P96S) substitution was included due to its importance on histidine
kinase activity of NM23-H1 (Freije et al., 1997). The relevance of this residue
on the DNA cleavage activity needed to be further examined. Taken together,
the complete generation of variant NM23-H1 mutants would provide a useful
foundation to study the anti-metastatic function of the molecule.
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Figure 3. The structure of NM23-H1 (A) Amino acid sequence and
schematic representation of NM23-H1 indicating major secondary structural
features, the α helices, β sheets and Kpn loop. The substituted amino acids
are labeled in bold font. (B) Ribbon diagram of an NM23-H1 monomer, folding
as four-stranded anti-parallel β sheets surrounded by α helices. (C) Spacefilling model of the NM23-H1 hexamer. Side chains of the substituted amino
acid residues are labeled as indicated.
A.

B.
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C.

18

2.2. Materials and Methods

2.2.1. DNA and site-directed mtagenesis
cDNAs encoding the NM23-H1 mutant variants Q17N, Y52A, D54A and
P96S were generated by the overlap extension modification of the polymerase
chain reaction (PCR), as described (Ho et al., 1989), and were inserted in
frame between the NdeI and BamHI sites of the E. coli expression plasmid
pET3c (New England Biolabs). The E5A mutant was constructed using the
QuikChange site-directed mutagenesis kit (Stratagene). The mutagenic
primers to construct the E5A, Q17N, Y52A, D54A and P96S mutants are shown
in Table 1 (codons encoding the mutant residue are underlined in bold font).
The

cloned

PCR

products

were

sequenced

by

ACGT

and

Elim

Biopharmaceutical Inc. to ensure that only the desired mutation was present.
pET3c plasmids containing wild-type NM23-H1 and the H118F mutant were
kindly provided by E. Postel (Princeton University), while construction of K12Q
was described previously (Ma et al., 2004).
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Table 1. The mutagenic primers to construct the E5A, Q17N, Y52A, D54A
and P96S mutants. Codons encoding the mutant residue are underlined in
bold font.

NM23-H1
mutation
E5A
Q17N
Y52A
D54A
P96S

Forward mutagenic primer
5’Æ3’
ATG GCC AAC TGT GCT CGT
ACC TTC
CCA GAT GGG GTC AAC
CGG GGT CTT
AAG GAA CAC GCC GTT
GAC CTG AAG G
GAA CAC TAC GTT GCC CTG
AAG GAC CG
GAG ACC AAC TCA GCA
GAC TCC
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Reward mutagenic primer
5’Æ3’
GAA GGT ACG AGC ACA
GTT GGC CAT
AAG ACC CCG GTT GAC
CCC ATC TGG
C CTT CAG GTC AAC GGC
GTG TTC CTT
CG GTC CTT CAG GGC AAC
GTA GTG TTC
GGA GTC TGC TGA GTT
GGT CTC

2.2.2. Overexpression and purification of recombinant human NM23-H1
and NM23-H2 proteins
NM23-H1 and mutant proteins were expressed and purified by our
standard protocol as previously described (Ma et al., 2004; Ma et al., 2002).
Briefly, pET3c vectors containing wild-type and variants of NM23-H1 were
used to transform E. coli (BL21 plysS; Promega). For protein expression,
freshly transformed bacteria were grown overnight at 37 °C in LB-ampicillin
medium. Two ml of the overnight culture was used to inoculate 200 ml of LB
medium containing ampicillin. When A600 reached 0.6, protein expression
was induced by the addition of isopropyl-1-thio-β-D-galactopyranoside (final
concentration of 0.4 mM). Three hours following the induction, cells were
harvested, resuspended in 30 ml of lysis buffer (50 mM Tris, pH 8.0)
containing 1 mM EDTA and dithiothreitol, 1 mM leupeptin and pepstatin A,
and 0.1 mM phenylmethylsulfonyl fluoride (Sigma), and then lysed by
sonication. Cell lysates were cleared by centrifugation at 12,000 x g for 30 min
and proteins were precipitated with ammonium sulfate (60-90% fractions).
The 60-90% fraction was prepared for application to a DEAE-Sephacel
column by dialysis into 50 mM Tris buffer (pH 7.5) containing a mixture of
protease inhibitors. Next, NM23-H1 bound to the column was eluted with a 0–
1 M NaCl gradient and peak fractions at ~350 mM NaCl were collected. Peak
fractions containing NM23 proteins were equilibrated in 10 mM phosphate
buffer (pH 7.0) by centrifugal filtration (Centricon-10, Millipore) and loaded
onto a hydroxyapatite (HTP) column. NM23-H1 was eluted with an 80-ml
phosphate gradient of 10-800 mM (pH 7.0). Purity of recombinant proteins
was evaluated by SDS-PAGE and Commassie Blue and/or silver staining.
NM23-H2 proteins were expressed and purified by the same procedure as
NM23-H1 except that NM23-H2 plasmids were transformed into E. coli BL21
strain (Promega), not BL21 plysS.

2.2.3. 3’-5’ exonuclease assay
The reactions were performed as described (Ma et al., 2002) with a
single-stranded, 33-base oligodeoxyribonucleotide substrate corresponding to
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the noncoding strand of the 5’-SHS silencer element (5’-SHS antisense strand,
or 5’-SHSas) from the platelet-derived growth factor A gene (Liu et al., 1996).
5’-termini were radio-labeled in a 40-µl reaction mixture at 37 °C for 30 min
using [γ-32P]ATP and T4 polynucleotide kinase. DNA cleavage reactions were
conducted at ambient room temperature in a 15-µl volume containing 20 mM
Hepes buffer (pH 7.9), 10-20 fmol of 5’-[32P]-labeled oligonucleotide, 2 mM
MgCl2 and 100 mM KCl, and were initiated by the addition of 1 µg NM23-H1
(640nM). Reactions were terminated by adding an equal volume of
sequencing loading dye consisting of 80% deionized formamide (w/v), 10 mM
EDTA (pH 8.0), xylene cyanol FF (1 mg/ml), and bromphenol blue (1 mg/ml)
followed by heating at 95 °C for 5 min. Cleavage products were resolved on
14% sequencing gels and visualized by phosphoimaging (Storm 860,
Amersham Biosciences).
.2.2.4. Nucleoside-diphosphate kinase assay
NDPK activity of NM23-H1 and variant mutants was measured as
described

(Agarwal

et

al.,

1978)

by

a

coupled

pyruvate-lactate

dehydrogenase assay in which ATP acted as a phosphate donor and dTDP
as an acceptor. The procedure was modified for the use of 96-well plates and
microplate reader (Ma et al., 2004). NDPK reactions were initiated by the
addition of 10 µl of purified NM23-H1 (10-50 ng) to a 140-µl reaction mixture
containing 1 mM pyruvate enol phosphate, 5 mM ATP, 2.5 mM dTDP, 6 mM
MgCl2, 50 mM KCl, 1000 units of pyruvate kinase and lactate dehydrogenase
in 100 mM Tris-HCl, pH 7.4. NAD+ formation, which reflected ADP production,
was measured every 25 seconds at 340 nm by a HTS 7000 plus Bioassay
Plate Reader (PerkinElmer). Specific activity was expressed as units/mg of
protein, with 1 unit defined as the amount of enzyme converting 1 µmol of
ADP/min at room temperature (ε340 of NADH = 6.22 x 103 M-1 cm-1).
2.2.5. Circular dichroism analysis
Far UV-CD spectra were recorded from 260 to 190 nm using a Jasco J810 spectrometer, with each individual spectrum representing the average of
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30 replicate measurements. Prior to analysis, purified NM23-H1 proteins were
diluted to a concentration of 0.12 mg/ml in 5 mM phosphate buffer (pH 7.0)
(ε280 = 1.35 for a 1 mg/ml solution; (Lascu et al., 1997)). CD spectra were
recorded at 5 °C in a quartz cuvette with a 0.1-cm path-length. CD data were
converted to mean residual ellipticity, assuming a hexameric structure and
mean residue molecular mass of 113 Da, the latter calculated from a 152amino acid monomer with a molecular mass of 17,180 Da (Rosengard et al.,
1989). Secondary structure estimates were derived from the 250–190 nm
region of the recorded CD spectra using the programs CONTILL, SELCON3,
and CDSSTR and their reference set of 43 proteins (Sreerama and Woody,
2000) from CDPro software package (lamar.colostate/edu~sreeram/CDPro/).

2.2.6. High performance liquid chromatography (HPLC) gel filtration
Purified wild-type or mutant variants of NM23-H1 were analyzed as
described (Ma et al., 2004). Briefly, proteins were loaded on a Shodex gel
filtration HPLC column (Shodex Protein KW-800, Showa Denko) preequilibrated in 50 mM Tris-HCl (pH 7.5), 0.1 M KCl. Molecular weights of
NM23-H1 were estimated relative to a standard curve generated with a
commercially available molecular mass standards kit (Sigma) containing
cytochrome C (12.4 kDa), carbonic anhydrase (29 kDa), bovine serum
albumin (66 kDa), alcohol dehydrogenase (150 kDa), β-amylase (200 kDa),
and blue dextran (2,000 kDa).

2.3. Results

2.3.1. DNA sequencing verified only the desired mutations present
The site of the substituted amino acids in the sequence of NM23-H1 is
indicated in Figure 3, panel A and C. The cloned PCR products were
sequenced by sense and anti-sense strands to ensure that only the desired
mutation was present (Figure 4).
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Figure 4. Sequence verification of PCR-generated cDNAs of NM23-H1
mutants. Double strands of cloned NM23-H1 DNA were sequenced to verify
that only the desired substitution was present. The substituted nucleotides
were underlined in the histogram profile. (A) E5A-H1 (B) Q17N-H1 (C) Y52A-H1
(D) D54A-H1 (E) P96S-H1
A.

E(gag)ÆA(gct)

B.

Q(cag)ÆN(aac)
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C.

Y(tac)ÆA(gcc)

D.

D(gac)ÆA(gcc)

E.

P(cct)ÆS(tca)
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2.3.2. Recombinant NM23-H1 and NM23-H2 proteins were overexpressed
and purified
NM23-H1 variants were purified with a three-step protocol consisting of
ammonium sulfate precipitation and sequential chromatographic steps of
DEAE-Sephacel and hydroxylapatite. Compared to the elution time of wildtype NM23-H1 (82-83 min, Figure 5, panel A) from the hydroxylapatite column,
the P96S mutant (Figure 5, panel E) was eluted slightly earlier (81-82 min); the
Y52A mutant (Figure 5, panel D) was eluted much earlier (69-70 min); the E5A
mutant (Figure 5, panel B) was eluted slightly later (84-85 min); while The
Q17N was eluted at the same position of the phosphate gradient as the wildtype protein (Figure 5, panel C, 82-83 min),
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Figure 5. Hydroxylapatite column chromatography of wild-type and
mutant NM23-H1. Figures shown below are elution profiles from the final step
of purification involving HTP column chromatography. HTP chromatography
was conducted using a Waters HPLC system at a flow rate of 1 ml/min, with
NM23-H1 proteins eluted using an 80-ml gradient of potassium phosphate
(10–800 mM, pH 7.0) and the collection of 1-min fractions. Within each of
panels A–E, A280 profile (top) and analysis of column fractions by SDSPAGE gel with Coomassie staining (bottom) are shown. The elution time of
the NM23-H1 variants from the HTP column are (A) 82-83 min for wild-type
H1. (B) 84-85 min for E5A-H1. (C) 82-83 min for Q17N-H1. (D) 69-70 min for
Y52A-H1. (E) 81-82 min for P96S-H1.
A.
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B.

C.
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D.

E.
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2.3.3. 3’-5’ Exonuclease activity of NM23-H1 mutants was measured
To assess the effects of these amino acid substitutions on DNA cleavage
activity, 1 µg of wild-type or mutant NM23-H1 protein was incubated with 10–
20 fmol of 5’-[32P]-labeled 5’-SHSas oligodeoxyribonucleotide at 22 °C during
a 1-hour time course (5, 10, 15, 20, 40, 60min) in the presence of 2 mM
MgCl2 and 100 mM KCl. Cleavage products were analyzed by electrophoresis
through

denaturing

14%

polyacrylamide

gel

and

visualized

by

phosphorimaging. Wild-type NM23-H1 elicited the rapid appearance of
products representing progressive removal of single nucleotides from the 3’
terminus with increasing incubation time (Figure 6A, lanes 2-7). 60 minutes of
incubation yielded substantial DNA fragments ranging between 15 and 17 nt
(Figure 6A, lane 7). The Q17N and P96S mutants produced very similar
cleavage activity as the wild-type H1, presenting time-dependent appearance
of progressive single nucleotide digestion from 3’ terminus to 5’ terminus on
the single strand DNA substrate (Figure 6A, lanes 8-13 and 14-19,
respectively). The Y52A mutant generated less digested fragments than the
wild-type protein, while still yielding a considerable quantity of the 15–33-nt
series of fragments (Figure 6A, lanes 20-25). Digestion by the E5A mutant are
significantly reduced, evidenced by much slower rate of depletion of the fulllength substrate (Figure 6A, lanes 26-31). The results of cleavage activity of
the E5A, Q17N, Y52A and P96S mutants were consistently seen with three or
more replicate preparations of each protein. The diminished 3’-5’ exonuclease
activity of the E5A mutant indicated a potential role for Glu5 in the catalytic
mechanism. Therefore, besides Lys12, a critical site of DNA cleavage activity
as previous reported (Ma et al., 2004), Glu5 is another amino acid residue
important for 3’-5’ exonuclease activity of NM23-H1.
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Figure 6. 3’-5’ exonuclease activity of purified NM23-H1 mutants. A, 1 µg
of wild-type (WT) or mutant (Q17N, P96S, Y52A, E5A) NM23-H1 protein was
incubated with 10 fmol of
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P-labeled 5’-SHS-AS oligodeoxynucleotide under

standard cleavage assay conditions during the indicated time. B, Cleaved
products were quantified by phosphorimaging to derive the cleaved amount of
nucleotides.
A.

B.

31

2.3.4. NDPK activity of NM23-H1 mutants was measured
NDPK activity was measured using a coupled pyruvate kinase/lactate
dehydrogenase assay as described previously (Agarwal et al., 1978; Ma et al.,
2004). The average specific NDPK activity of wild-type NM23-H1 was 630
units/mg. Compared to this, the E5A and Q17N mutants retained 70-80%
NDPK activity of the wild-type (440 units/mg and 520 units/mg, respectively,
Table 2), consistent with the effect of Q17N-H2 mutant on this kinase activity
(Postel et al., 2002). The NDPK activity of the P96S mutant was 127 units/mg
(Table 2), not consistent with a previous report, in which it was shown the
P96S-H1 mutant retained full NDPK activity (Freije et al., 1997). However, this
inconsistency is not surprising, because the Freije group used a different
method from the one we used. They determined the formation of [γ-32P]GTP
from non-radioactive GDP when incubated with [γ-32P]ATP and NM23-H1.
However, the method we used was to quantify the specific activity of the
enzyme, which was more accurate and reliable. Finally, the NDPK activity of
Y52A mutant was dramatically inhibited (below the detection limits; Table 2),
indicating Y52 was likely to play a critical role in the NDPK activity of NM23-H1.
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Table 2. NDPK, histidine kinase and 3’-5’ exonuclease activities for
NM23-H1 variants.
NDPK

Protein

activity
WT
E5A
K12Q
Q17N
Y52A
P96S
H118F

1

627 ± 36e
438 ± 31d
14 ± 0.9b,4
516 ± 10d
a

B.D.
127 ± 5c

a,4

B.D.

Histidine Kinase
% of
WT
100
70
2
82
0
20
0

2

activity
9.9
8.2
0.9
6.5
0.4
1.1
B.D.

% of
WT
100
83
9
66
4
11
0

3’-5’ Exonuclease
3

activity

28.4 ± 4.0
3.4 ± 1.5*
5.2 ± 3.5*
31.4 ± 6.0
25.3 ± 3.9
24.9 ± 5.1
33.0 ± 9.0

% of
WT
100
12
18
110
89
88
116

1

NDPK activity is expressed as the mean ± S.E. in units/mg proteins, derived

from at least three different protein preparations.
2

Histidine kinase activity is expressed as a percent of substrate converted per

minute. (Assays performed by Robert McCorkle.)
3

Exonuclease activity is expressed in fmol/5min (mean ± S.E.) and is derived

from at least three assays conducted with at least three independent protein
preparations.
4

Values shown for NDPK activity of K12Q and H118F were published previously

(Ma et al., 2004).
a-d

Means not showing a common superscript are significantly different (p ≤

0.01).
*

Means bearing an asterisk within a column are significantly different (p ≤

0.05).
B.D., below detection.
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2.3.5. Oligomeric structure of NM23-H1 mutants was not significantly
changed based on molecular weight estimates
The purified mutant NM23-H1 variant proteins were further analyzed by
gel filtration HPLC to estimate oligomeric structure and molecular weight. Two
peaks were observed with wild-type NM23-H1 protein (Figure 7), a primary
peak at approximately 18.74 min with an estimated molecular mass of 87.7
kDa (Table 3) and a minor peak at about 17.1 min. Our previous evidence
showed that the DNA cleavage activity precisely coeluted with the primary
peak of oligomerized NM23-H1 protein (Ma et al., 2004), suggesting the minor
peak could be some nonspecific copurified contaminants. The primary peak of
NM23-H1 mutants was observed at 18.78(E5A), 18.76(Q17N), 18.90(Y52A) and
18.79(P96S) minute, respectively. Molecular weight estimates obtained by gel
filtration HPLC for E5A, Q17N and P96S were not significantly different from
that of wild-type NM23-H1 (Table 3). Y52A exhibited a small, but statistically
significant decrease (9 kDa) in apparent size. However, this small decrease
was not consistent with an effect on oligomeric structure and was possibly
due to anomalous interaction of this aromatic-structure-changed variant with
the gel filtration matrix. In summary, none of the mutations resulted in
significant disruption of oligomeric structure of the NM23-H1 molecule.
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Figure 7. Gel filtration HPLC of wild-type and mutant NM23-H1. Purified
wild-type or mutant NM23-H1 proteins were loaded on a Shodex gel filtration
HPLC column (Shodex Protein KW-800) pre-equilibrated in 50 mM Tris (pH
7.5) and 0.1 M KCl at a flow rate of 0.5 ml/min. Elution times of the molecular
mass standards (Sigma) cytochrome c (12.4 kDa), carbonic anhydrase (29
kDa), bovine serum albumin (66 kDa), alcohol dehydrogenase (160 kDa), βamylase (200 kDa), and blue dextran (2000 kDa) are indicated with arrows.
The primary peaks of the NM23-H1 variants eluted from the gel filtration
column are (A) 18.74 min for wild-type NM23-H1. (B) 18.78 min for E5A-H1.
(C) 18.76 min for Q17N-H1. (D) 18.90 min for Y52A-H1. (E) 18.79 min for P96SH1.
A.

B.
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C.

D.

E.
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Table 3. Molecular weight estimates of NM23-H1 mutants.
Protein
WT
E5A
Q17N
Y52A
P96S
1

Estimated Molecular Weight
87.7 ± 2.1
85.1 ± 7.1
86.3 ± 1.5

1

*

78.4 ± 3.0
84.7 ± 0.4

Results were obtained by gel filtration HPLC and are expressed as the mean

± S.D. in kDa of three replicate determinations (> 2 independent protein
preparations).
*

Means within a column bearing an asterisk are significantly different (p<0.05).
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2.3.6. Circular dichroism analysis indicated NM23-H1 mutants exhibited
normal secondary structure
To measure the extent to which the mutations affected secondary
structure of the NM23-H1 molecule, purified proteins were analyzed by
circular dichroism (CD) spectrometry. The CD spectra obtained for the wildtype NM23-H1 (Figure 8) were consistent with the previous report (Ma et al.,
2004) using the same procedure. The secondary structure estimates of wildtype NM23-H1 were 14% of total α-helix, 33% of β-sheet, 20% of turns, and
33% of random (Table 4). The CD spectra associated with the E5A, Y52A and
P96S variants were similar to the wild-type, while the Q17N yielded slightly
lower helix and higher sheet content than that of wild-type (Table 4). Taken
together, the gel filtration and CD spectral analyses indicated that each of the
NM23-H1 mutants employed in this study exhibited normal oligomeric and 3dimensional structure.
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Figure 8. Circular dichroism (CD) analysis of recombinant NM23-H1
variants. 1.2 µM of purified wild-type (WT) and mutant NM23-H1 proteins
(E5A, Q17N, Y52A and P96S) were analyzed by CD spectra at 5 oC in a 200-µl
cuvette (0.1-cm optical path), as described previously (Ma et al., 2004). Each
spectrum was the average of 30 measurements and data were expressed as
molar ellipticity.
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Table 4. Secondary structure estimates of NM23-H1 mutants.
Protein
WT
E5A
Q17N
Y52A
P96S
1

α Helix
14.2 ± 2.8
10.7 ± 2.2
8.8 ± 2.6
11.4 ± 4.1
13.7 ± 1.7

CD spectrometry1
β Sheet
Turns
32.6 ± 5.3
20.0 ± 0.1
35.0 ± 2.5
19.4 ± 0.6
40.2 ± 4.3
18.7 ± 2.0
35.9 ± 1.9
19.4 ± 1.4
33.0 ± 1.2
19.8 ± 1.3

Random
32.6 ± 3.8
32.9 ± 1.8
32.3 ± 0.7
30.7 ± 1.1
32.7 ± 2.0

Secondary structure content is expressed as a percent of the total structure

and it represents the mean ± S.D. of estimates provided by the three different
structure prediction programs Contin, Selcon3 and CDSSTR from the online
DICHROWEB server (lamar.colostate/edu~sreeram/CDPro/).
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2.4. Discussion
To assess the relevant roles for each of these biochemical activities of
NM23-H1 in metastasis suppression, we created a panel of NM23-H1 variants
with selective enzymatic lesions. Previous reports showed that a His118Æ Phe
(H118F) substitution totally disrupted NDPK activity but did not affect 3’-5’
exonuclease activity, while a K12Q mutation disrupted both NDPK and 3’-5’
exonuclease activities (Ma et al., 2004). In the current study, we show that the
histidine kinase (hisK) activity is also inactivated in each of the
aforementioned mutants (H118F-0% of WT; K12Q-9% of WT; Table 2).
Therefore, the K12Q mutant harbors profound lesions in all three enzymatic
activities (98% reduction in NDPK, 91% loss of hisK, and 82% loss of 3’-5’
exonuclease), indicating that Lys12 is required for all enzymatic activities
associated with NM23-H1. More importantly, E5A substitution results in a
dramatic and selective disruption in 3’-5’ exonuclease capacity (12% of WT)
without significant effect on either NDPK or hisK activity, suggesting that the
active site for the kinase and exonuclease activities could be separated.
Moreover, loss of the DNA cleavage activity in the E5A and K12Q mutants
further confirms that the 3’-5’ exonuclease activity of NM23-H1 is not due to
contamination by bacterial nucleases but is an intrinsic activity of the proteins.
Interestingly, although both of Lys12 and Glu5 are necessary for DNA
cleavage activity of NM23-H1, their mechanisms of action are not the same.
In contrast to lysine acting as a critical nucleophile through the ε-amino group,
glutamic acid functions as a nuclease by binding the γ-carboxyl group with
divalent cation (Shen et al., 1996). Both of these amino acids are highly
conserved in human NM23 homologues from H1 to H5.
Analysis of these mutant proteins by circular dichroism spectrometry
revealed that none of the amino acid substitutions resulted in significant
alterations in the secondary structure of NM23-H1. Therefore, losses in
enzymatic activity observed in this study are likely to reflect specific roles for
the respective amino acid residues in enzyme activity.
The enzymatic activities of NM23-H1 demonstrated in vitro could have
potential implications for such in vivo processes as DNA replication and repair.
Conversely, loss of these functions would be expected to lead to accelerated
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mutation rates, thereby promoting the malignant progression. To test our
hypothesis that the 3’-5’ exonuclease activity of NM23-H1 may underlie the
biochemical mechanism of metastasis suppressor by its potential DNA repair
function, the panel of H1 mutants was generated. The enzymatic deficient H1
mutants would permit identifications of the relevant enzymatic activity of
NM23-H1.

For

example,

in

metastatic

tumor

cells

with

NM23-H1

overexpression, wild-type-H1 should inhibit the metastatic characterizations of
the malignant cell while mutant H1 is likely to lose the suppressing effect. The
defect of the anti-metastatic function would be correlated to the inactivated
enzymatic activity of mutant H1. The K12Q mutant, harboring lesions in all
three enzymatic activities, makes it difficult to determine the relevant
biochemical mechanisms. However, the identification of the E5A mutant in this
study is promising, because it is the only mutant selectively deficient in
exonulease activity. Thus, the E5A mutant would provide the possibility to
discover the relationship between the 3’-5’ exonuclease activity and the
metastasis-suppressing function of NM23-H1.

Copyright © Mengmeng Yang 2008
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CHAPTER THREE
3’-5’ EXONUCLEASE ACTIVITY OF NM23-H1 PLAYS A CRITICAL ROLE
IN SUPPRESSING IN VIVO SPONTANEOUS METASTASIS

3.1. Introduction
NM23-H1 proteins have been shown to possess multiple enzymatic
activities, in which nucleoside diphosphate kinase (NDPK), histidine protein
kinase (hisK) and 3’-5' exonuclease (3’-5’ EXO) activities have been
extensively investigated. Of these enzymatic activities, 3’-5' exonuclease
activity of NM23-H1 was identified by our laboratory recently (Ma et al., 2004;
Ma et al., 2002). However, the relevant biochemical mechanisms underlying
metastasis suppressor function of NM23-H1 are not very clear yet. The 3’-5’
exonuclease activity is a plausible candidate due to the association of the
enzyme with DNA repair processes and the mutator phenotype often arises
as a consequence of its deficiency (Shevelev and Hubscher, 2002). Moreover,
accumulation of mutations is suggested to be required for metastatic
progression which permits tumor cells to overcome barriers to achieve
metastases (Loeb, 1991, 2001). Thus we hypothesize that 3’-5’ exonuclease
activity of NM23-H1 plays an important role in maintaining genomic stability
and in turn suppressing metastatic progression of tumor cells. To test this
hypothesis, we have generated a panel of NM23-H1 mutants, including H118F
(NDPK−, hisK−, EXO+), P96S (NDPK+, hisK−, EXO+), K12Q (NDPK−, hisK−,
EXO−) and E5A (NDPK+, hisK+, EXO−). The metastasis-suppressing activities
of these variant NM23-H1 mutants will be analyzed by in vitro and in vivo
metastasis assays. Loss of anti-metastatic function will be related to the
inactivated biochemical activity of NM23-H1 mutants. The 3’-5’ exonuclease
activity was selectively disrupted in the E5A mutant, providing an insight into
the role of this enzymatic activity in metastasis suppression. Furthermore, this
panel of NM23-H1 mutants also includes the NDPK and histidine kinase
deficient mutants (H118F and P96S respectively), the contribution of NDPK and
histidine kinase activities to the metastasis suppressor function can be
analyzed by the metastasis assays as well.
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Metastasis can be quantified by in vivo assays. There are two types of
xenograft metastasis assays, spontaneous and experimental (Welch, 1997).
In a spontaneous metastasis assay, tumor cells are injected into tissue sites
(i.e. subcutaneously, intradermally, intramuscularly, or into specific organs or
tissues) which results in formation of a local tumor that will eventually give rise
to spontaneous metastases. This assay measures the complete metastatic
process but requires long post-injection time for completion. In an
experimental metastasis assay, tumor cells are injected into the bloodstream
of rodents and metastases form quickly and in greater numbers, but this
assay circumvents the early steps of metastasis, such as local tumor growth
and intravasation. Full characterization of any metastasis model system
should include both assays. In our experimental design, a highly metastatic
melanoma cell line 1205Lu was selected to measure the anti-metastatic
characteristics of NM23-H1 by both in vivo metastasis assays. The melanoma
cell line 1205Lu was established from lung metastatic lesions in mice after
subcutaneous injection of WM793 cells, while the WM793 cell line from the
vertical growth phase of melanoma represents premetastatic cells. The stably
transfected 1205Lu cells with wild-type and mutant NM23-H1 variants were
subcutaneously injected in spontaneous assay and intravenously injected in
experimental assay. In both models, mice developed lung nodules, therefore
recapitulating all the steps from primary solid tumor formation to metastatic
spread.

3.2. Materials and Methods
3.2.1. Plasmids construction
cDNAs encoding the NM23-H1 mutants K12Q, P96S and H118F were
generated by the overlap extension modification of the polymerase chain
reaction (PCR), as described (Ho et al., 1989). They were inserted in frame
between the XhoI and EcoRI sites of the pCI-neo mammalian expression
vector (Promega). The E5A mutant was constructed using the QuikChange
site-directed mutagenesis kit (Stratagene). The pCI vector carries the
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cytomegalovirus (CMV) promoter for high level of DNA expression and the
neomycin phosphotransferase gene for the selection of stable transfected
clones. Additionally, in this vector the GFP is co-expressed with NM23-H1 in
an IRES (Internal Ribosome Entry Segment) expression cassette. The cloned
PCR products were sequenced by ACGT and Elim Biopharmaceutical Inc. to
ensure that only desired mutations were present.
3.2.2. Animals
Female athymic nude mice (Harlan, nu/nu; 6-8 weeks old) were obtained.
Care of mice, surgery and injection protocols were approved by the IACUC at
the University of Kentucky Medical Center (protocol # 00319M2001 and
00801M2004). The mice were determined to be free from pathogens and
caged in groups of four in facilities meeting National Institutes of Health
guidelines. The mice were euthanatized by intraperitoneal injection of sodium
pentobarbital (Nembutal, Sigma) at dose of 60 mg/kg.
3.2.3. Cell culture, stable transfection and flow cytometry
1205Lu melanoma cells were cultured in MCDB153/L15 medium (Sigma;
v/v: 4/1) supplemented with CaCl2 (2 mM), insulin (5 mg/ml) and 2% fetal
bovine serum (FBS) (Gibco). 1205Lu melanoma cells were stable transfected
with plasmid DNA of wild-type and mutant nm23-H1 (Fugene 6, Roche) and
selected by geneticin (G418, Life technologies; 250 µg/ml). Cells were sorted
by fluorescence-activated cell sorting (FACS) using a FACS Calibur Flow
Cytometer. The sorting procedure yielded more than 95% GFP fluorescent
cells.
3.2.4. Spontaneous lung metastasis assay
The parent or variant H1-expressing 1205Lu cells were harvested by a
brief exposure to PBS. Cell numbers and viability were examined using trypan
blue. Single-cell suspensions of >90% viability were resuspended at 1 x 106
cells in 100 µl of Hank’s balanced salt solution (Gibco). 2 x 106 1205Lu cells
of each group were injected subcutaneously into the flank of athymic nude
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mice. The growth of the tumors was monitored and measured at 3-day
intervals using vernier caliper. Tumor volumes were calculated by the
following formula: volume=0.52 x A x B2, where A is the larger and B is the
smaller axis (Tomayko and Reynolds, 1989). Mice were anesthetized under
isoflurane and the primary tumors were removed when the tumor size
reached 0.8-1 cm3. The removed primary tumors were checked for
fluorescence using Kodak Image Station 4000. The mice were raised for
another 3 months to permit metastatic growth. At the end of the experimental
period, mice were euthanatized and lung metastases were scored by counting
metastatic nodules. The whole procedure of spontaneous metastasis assay is
illustrated in Figure 9A.
3.2.5. Experimental lung metastasis assay
The metastatic potency of 1205Lu parent cells and variant NM23-H1
transfectants were also determined using an “experimental metastasis assay”
(Kath et al., 1991). 2 x 106 parent cells or variant mutant H1-expressing
1205Lu cells (in a volume of 0.1 ml Hank’s buffer) were injected into the
lateral tail veins of nude mice. Animals were sacrificed after 1 month and the
lungs were fixed in Bouin’s solution and scored for metastatic nodules. As
shown in Figure 9B, the procedure of experimental metastasis assay is
exhibited.
3.2.6. Statistical analysis
The proportion of metastasis was compared among the seven groups by
constructing a chi-square statistic for a 7 by 2 contingency table. If significant,
group response rates will then be compared one to the other by chi-square
statistics or Fisher’s exact test for a series of 2x2 contingency tables.
Statistical significance was determined if P < 0.05.
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Figure 9. Illustration of procedures of in vivo metastasis assays.
(A) In spontaneous metastasis assay, 2x106 1205Lu parent or nm23-H1
variant transfected cells were injected subcutaneously into the flank of nude
mice. When the tumor size reached 0.8-1 cm3, the primary tumors were
removed and mice were continually raised for three months to permit
formation of lung metastases. At the end of the experiment, mice were
sacrificed and lung nodules were counted. (B) In experimental metastasis
assay, 2x106 1205Lu parent or transfected cells were injected directly into tail
vein of nude mice. One month later, mice were sacrificed and metastatic lung
nodules were scored.
A.
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B.
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3.3. Results
3.3.1. NM23-H1 expression does not affect primary tumor growth of
1205Lu melanoma cells.
Parent and stably transfected 1205Lu cells with NM23-H1 variants were
injected subcutaneously into athymic nude mice and the growth of primary
tumors were monitored over time. The sizes of primary tumors were
measured by calipers and after four weeks, tumor volumes reached 0.8-1.0
cm3. As shown in Figure 10, the primary tumor formed by wild-type NM23-H1
transfected 1205Lu cells was not significantly different from that of parent
cells, suggesting expression of wild-type-H1 had no inhibitory effect on
primary tumor growth of 1205Lu cells in vivo. Once the size of primary tumor
reached 0.8-1.0 cm3, tumors were removed and mice were continually raised
for another 3 months to form lung metastases.
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Figure 10. NM23-H1 expression does not affect primary tumor growth.
2x106

parent

and

variant

NM23-H1-expressing

1205Lu

cells

were

subcutaneously injected on the flanks of mice to form primary tumors. The
size of primary tumors was measured by calipers every 3-4 days. Primary
tumor growth from wild-type NM23-H1, H118F-H1 and P96S-H1 transfected
cells had no significant difference compared to that of 1205Lu parent cells.
The tumor formed in K12Q-H1- and E5A-H1-transfected cells exhibited slower
growth than parent cells after day 20, however, they still reached the target
size of 0.8-1.0 cm3 on day 30 (5 days later than other groups).
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3.3.2. The E5A and K12Q mutations disrupt metastasis suppressor
activity of NM23-H1.
Three months after the primary tumors being removed, all mice were
sacrificed and lungs were examined for metastatic nodules. Lung metastases
were scored as plus or minus and metastasis rate was calculated by number
of mice with lung metastasis over total number of mice in this group. As
shown in Table 5, a 64% metastasis rate was observed in the parent 1205Lu
cells, a relatively high penetrance for this cell line. Expression of the wild-type
NM23-H1 significantly suppressed the spontaneous metastasis rate to 24%,
consistent with its previously described metastasis suppressor activity (Table
5). Unexpectedly, the P96S mutant exhibited full metastasis suppressor activity
(Table 5), in contrast with previous reports (Hartsough et al., 2002). However,
the E5A and K12Q mutations resulted in a nearly complete loss of suppressor
activity (Table 5). The H118F mutant also exhibited less metastasissuppressing activity than the wild-type, but the reduction failed to achieve
statistical significance. As shown in Figure 11, the spontaneous lung
metastases from 1205Lu parent cells and E5A-H1 group were much more
severe than that of the wild-type group.
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Table 5. The K12Q and E5A mutations result in complete loss of
metastasis suppressor activity for NM23-H1. After primary tumors were
excised, mice were raised for another 3 months to permit lung metastases. At
the end of the experiment, all mice were sacrificed at the same day and lungs
were examined for metastatic nodules. Metastasis rate in each group is
presented as a percent of number of mice with lung metastasis/total mice
number in this group.

1205Lu cell lines

# of mice with lung
metastasis/ # of total mice1

Parent
WT-H1
E5A
K12Q
P96S
H118F

14/22
9/37
13/26
14/24
6/24
8/20

Percentage rate
64a,b
24c
50a,b
58a,b
25c
40a,b,c

1

Qingbei Zhang and Marian Novak contributed to the data shown above.

a,b,c

Values not sharing a common superscript are significantly different (p <

0.05).
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Figure 11. Representative pictures of spontaneous lung metastases
from 1205Lu parent cell group (a and b), wild-type-H1 group (c and d)
and E5A-H1 group (e and f).
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3.4. Discussion
The molecular mechanism(s) underlying the metastasis suppressor
activity of NM23 proteins still remain controversial. Currently, the most widely
accepted model involves the histidine kinase (hisK) activity of NM23-H1 as
some evidence suggests that this enzymatic activity is necessary for inhibition
of cell motility and suppression of Map kinase activation via phosphorylation
of the kinase suppressor of Ras (KSR) in MDA-MB-435 breast carcinoma
cells (MacDonald et al., 1996). However, direct evidence for the relevance of
hisK to in vivo metastasis suppression has not been determined. In this study,
we propose that the 3’-5’ exonuclease activity of NM23-H1 plays an important
role in suppressing metastasis by maintaining genomic integrity. However, an
efficacious metastasis suppressor might be expected to exert multiple
activities at multiple levels. Therefore, our hypothesis does not exclude the
possibilities that other known enzymatic activities of NM23-H1 could also
contribute to the anti-metastatic function. To this end, a panel of variant
NM23-H1 mutants has been developed and used to systematically determine
the relevant contributions made by each of the primary enzymatic activities of
NM23-H1.
To assess the anti-metastatic function of NM23-H1, the human
metastatic melanoma cell line 1205Lu was chosen as an experimental model
in this project for a number of reasons. First, melanoma represents the
prototypical setting for the metastasis suppressor NM23-H1, since the
metastasis suppressor activity of NM23 was originally identified in the murine
melanoma cell line K-1735 (Steeg et al., 1988). Second, 1205Lu cells
exhibited highly metastatic characteristics in a number of in vitro and in vivo
models. Third, orthotopic tumor inoculation (subcutaneous injection) of
melanoma cells is easy to be performed on animals. Finally, and most
importantly, my colleague has demonstrated that 1205Lu cells expressed very
low amounts of NM23-H1 and NM23-H2 (Qingbei Zhang, Ph.D. dissertation,
2006), consistent with a classical model of reduced NM23 expression in
melanoma metastases. This low level of NM23 expression also provides a low
background upon which the anti-metastatic activity of wild-type and mutant
NM23-H1 can be determined.
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NM23-H1-expressing plasmids and pSV2neo were co-transfected into
1205Lu cell line. Stably transfected cells were selected by neomycin analogue
G418 and enriched by sorting of GFP-fluorescent cells. Same intensity of
GFP fluorescence in variant H1-transfected cells indicated that equal amount
of NM23-H1 was expressed. To measure the anti-metastatic ability of wildtype and mutant NM23-H1, parent and variant NM23-H1-expressing 1205Lu
cells were injected into athymic nude mice by standard approaches of
spontaneous and experimental metastasis assays.
In the spontaneous metastasis model, forced expression of wild-type
NM23-H1 had no effect on primary tumor growth of 1205Lu cells, but in K12QH1 and E5A-H1 overexpressed cells the primary tumor growths were slower
than that of parent cells. However, subsequent replication of these studies by
my colleague (Marián Novak) has demonstrated that there is, in fact, no
statistical difference in primary tumor growth rates. Therefore, NM23-H1 still
fits the definition of metastasis suppressor, by which it does not affect primary
tumor growth when inhibiting tumor metastasis.
At the end of this experiment, wild-type NM23-H1 and P96S mutant
significantly suppressed the spontaneous lung-metastasis rate of 1205Lu cells
to 24% and 25% respectively, while the K12Q and E5A mutants lost the
metastasis-suppressing effects exhibited by the wild-type-H1 (Table 5). Based
on these observations, the actions of these mutants on lung metastases need
to be discussed one by one. -1- Since E5A-H1 is an exonuclease-deficient
mutant with full NDPK and hisK activities, loss of metastasis suppressor
activity of this mutant would directly suggest that the 3’-5’ exonuclease activity
of NM23-H1 is required to suppress lung metastasis from melanoma lesion. 2- The histidine kinase activity of NM23-H1 seems not to contribute to the
metastasis suppressor function, since the hisK-deficient P96S mutant still
maintains the full anti-metastatic capacity. -3- The H118F mutant is deficient in
both NDPK and hisK activities. Since the apparent loss of anti-metastatic
activity with the H118F mutant was not statistically significant, relevance of the
NDP kinase to anti-metastasis function could not be demonstrated. -4- The
K12Q mutant lacks all three of these enzymatic activities and also disrupts the
metastasis-inhibiting capacity. As discussed above, if either NDPK or hisK
activity is not involved in the mechanism of metastasis suppression, 3’-5’
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exonuclease must be necessary to suppress metastasis in 1205Lu melanoma
cells, consistent with the result of the E5A group. Taken together, all these
results strongly indicate that 3’-5’ exonuclease activity of NM23-H1 plays
important roles in suppressing spontaneous lung metastasis in 1205Lu
melanoma cells. In contrast with a previous report that the histidine kinase
activity might mediate the metastasis suppressor function of NM23-H1
(Hartsough et al., 2002), in this study, it does not seem to be involved in this
function.
In the experimental metastasis assays (performed by my colleagues
Qingbei Zhang and Marián Novak) , the tail vein injection of 2x106 1205Lu
parent cells led to an 87% of metastasis. However, unlike what we expected,
overexpression of wild-type NM23-H1 didn’t significantly inhibit the lung
metastasis. These observations suggested that NM23-H1 lost the metastasis
suppressor function when a large number of melanoma cells directly entered
the blood system. These cells flowed to the lungs and were trapped within
pulmonary capillaries, followed by intravascular proliferation and eventual
colonization in the lung. In this process, early steps of the metastatic
progression were omitted, including the loss of cellular adhesion, increased
motility and invasion, entry and survival in the circulation. Therefore, the
experimental metastasis accelerated the metastatic period and increased the
metastatic efficiency. The observations that NM23-H1 was able to inhibit the
metastasis in the spontaneous metastasis model but not in the experimental
metastasis model suggested that NM23-H1 may mediate the suppressing
effects on the earlier steps of metastasis. This idea is supported by our in vitro
studies of 1205Lu cells, which showing that overexpression of wild-type
NM23-H1 inhibited motility and invasion of the cells (Qingbei Zhang, Ph.D.
dissertation, 2006). Another evidence is that forced expression of NM23-H1
inhibited anchorage independent growth in soft agar in MDA-MB-435 and
MDA-MB-231 cells (McDermott et al., 2007). Furthermore, overexpression of
NM23-H1 in human breast carcinoma cells led to the formation of basement
membrane and growth arrest (Howlett et al., 1994), which also supported the
idea that NM23-H1 performs a suppressor function in the early stages of
metastasis.
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Interestingly, the effects of NM23-H1 mutants on the in vivo spontaneous
metastasis assay of 1205Lu cells were consistent with an in vitro assay
developed in the Kaetzel laboratory using the non-metastatic melanoma cell
line WM793 (performed by Qingbei Zhang and Marián Novak). The WM793
cell line was derived from a vertical growth phase (VGP) melanoma, a highly
invasive but non-metastatic form of the disease. Expression of NM23 was
undetectable in this cell line. This non-metastatic cell line can progress to a
metastatic phenotype under strong selective pressure, such as culturing in
protein-free (growth factor-free) medium (Kath et al., 1991). The unpublished
data achieved by my colleagues demonstrated that forced expression of wildtype NM23-H1 significantly blocked the progression process of WM793 cells
in protein-free medium. Moreover, similar to the pattern observed in 1205Lu
cells, K12Q but not P96S mutant lost the effects of anti-progression exhibited
by wild-type-H1. This observation further demonstrated that 3’-5’ exonuclease
activity of NM23-H1 is likely to mediate the biochemical mechanisms in
metastasis suppression.
Evidence from in vivo spontaneous metastasis assay of 1205Lu cells
and in vitro progression assay of WM793 cells strongly indicates that the 3’-5’
exonuclease activity of NM23-H1 is important to suppress metastasis and
metastatic progression of melanoma cells. The underlying mechanisms could
be that 3’-5’ exonuclease activity participates in DNA repair or other aspects
of cellular function to maintain genomic integrity. The properties of NM23-H1
in maintenance of genomic stability will be addressed in next chapter.

Copyright © Mengmeng Yang 2008
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CHAPTER FOUR
ANALYSIS OF DNA REPAIR ACTIVITY FOR YNK1, THE YEAST
SACCHAROMYCES CEREVISIAE HOMOLOGUE OF METASTASIS
SUPPRESSOR NM23

4.1. Introduction
Nucleoside diphosphate kinase (NDPK) catalyzes the transfer of a γphosphate between nucleoside triphosphate and nucleoside diphosphate via
a “ping-pong” mechanism (Agarwal et al., 1978). NM23 is a highly conserved
enzyme from prokaryotes to eukaryotes, with their three-dimensional
structures showing remarkable similarity (Dumas et al., 1992), indicating that
NDP kinase evolution is highly conservative. In addition to NDPK activity,
NDP kinase has been determined to have a number of other important cellular
and biochemical functions in different species.
NM23-H1 was first identified by virtue of its reduced expression in highly
metastatic melanoma and breast carcinoma cells, and the ability of forced
NM23-H1 expression to inhibit metastatic potential without significant impact
on the transformed phenotype (Steeg et al., 1988). In addition to NDPK
activity, NM23-H1 also exhibits both protein histidine kinase (HisK) (Freije et
al., 1997) and 3’-5’exonuclease (3’-5’EXO) activities (Ma et al., 2004).
Generally, enzymes that contain 3’-5’ exonuclease activity are involved
directly in DNA repair processes and maintenance of genomic stability
(Shevelev and Hubscher, 2002). Here, we hypothesize that the loss of the 3’5’ exonuclease activity of NM23-H1 during tumor progression impairs
genomic integrity, thereby enhancing metastatic potential.
Previous studies provide compelling evidence on the potential DNA
repair functions of NM23. Ndk-disrupted strain of Escherichia coli exhibited a
mutator phenotype with significantly increased frequencies of spontaneous
mutations resistant to rifampicin and nalidixic acid (Lu et al., 1995). This is a
direct evidence for the anti-mutator function of the prokaryotic homologue of
NM23. In yeast mutagenesis studies, expression of YNK1, the budding yeast
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homologue of NM23, was significantly increased in response to treatment with
the DNA methylating agent methyl methanesulfonate (MMS) (Gasch et al.,
2001). In addition, our unpublished data show that NM23-H1 accumulates and
co-localizes with nuclear foci following the treatment with DNA damaging
agents etoposide, cisplatin and UV radiation. UV radiation seems to have a
stronger effect on this observation than etoposide and cisplatin. These DNA
damage responses further suggest a DNA repair function of NM23-H1.
In an effort to quantify the contribution of NM23-H1 to DNA repair, we
have initiated experiments in the yeast Saccharomyces cerevisiae. S.
cerevisiae provides an excellent eukaryotic model for DNA repair research,
since knockout strains are available for essentially all genes including those
involved in DNA repair mechanisms. These characteristics of S. cerevisiae
provide a genetic model for rapid and convenient analysis of the role of YNK1
in DNA repair. In this project, we measured the impact of deletion of the YNK1
on the mutation rate in S. cerevisiae.

4.2. Materials and Methods

4.2.1. Yeast strains and media
The single mutant strains (Open Biosystems) used as parent strains in
this study were derived from BY4741 or BY4742 wild-type strain and their
genotypes are listed in Table 6. The ORF for each gene of interest was
replaced with a KanMX-selectable marker by a PCR-based strategy. The
double mutant strain was constructed by crossing ynk1:: kanMX mutant with
an isogenic strain harboring another deletion in one of DDC1, RAD17, MEC3,
MSH2, and RAD27 genes. Genotypes were verified for resultant haploid
derivatives of each mutant strain by PCR analysis using primer pairs specific
for either the wild-type or mutant allele. Yeast strains were grown in standard
media including yeast extract/peptone/dextrose (YPD) medium or synthetic
drop-out medium (SD) lacking the appropriate amino acid. Canavanineresistant mutants (Canr) were selected on SD arginine-dropout plates
containing 60 mg/liter L-canavanine sulfate (Sigma).
59

Table 6. S. cerevisiae strains used in this study

Strain

Genotype

BY4741

a. his3∆1 leu2∆0 met15∆0 ura3∆0

BY4742

α. his3∆1 leu2∆0 lys2∆0 ura3∆0

ynk1

a. his3∆1 leu2∆0 met15∆0 ura3∆0 ynk1::kanMX

ddc1

α. his3∆1 leu2∆0 lys2∆0 ura3∆0 ddc1::kanMX

rad17

α. his3∆1 leu2∆0 lys2∆0 ura3∆0 rad17::kanMX

mec3

α. his3∆1 leu2∆0 lys2∆0 ura3∆0 mec3::kanMX

msh2

α. his3∆1 leu2∆0 lys2∆0 ura3∆0 msh2::kanMX

rad27

α. his3∆1 leu2∆0 lys2∆0 ura3∆0 rad27::kanMX

ynk1 ddc1

his3∆1 leu2∆0 met15∆0 ura3∆0 ynk1::kanMX ddc1::kanMX

ynk1 rad17

his3∆1 leu2∆0 lys2∆0 ura3∆0 ynk1::kanMX rad17::kanMX

ynk1 mec3

his3∆1 leu2∆0 ura3∆0 ynk1::kanMX mec3::kanMX

ynk1 rad27

his3∆1 leu2∆0 lys2∆0 ura3∆0 ynk1::kanMX rad27::kanMX

ynk1 msh2

his3∆1 leu2∆0 met15∆0 ura3∆0 ynk1::kanMX msh2::kanMX
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4.2.2. UV sensitivity assay
Individual colonies were inoculated into 1 ml of YPD medium and grown
overnight with shaking at 250 rpm at 30oC to a density of 2 x 108 cells/ml. 100
µl of the appropriate cell dilution were plated in triplicate on YPD agar plates
to assess cell survival. Within an hour of plating, cells were exposed to UV
light on a time course. After UV exposure the plates were immediately stored
in incubator at 30oC. Cell viability was the fraction of plated cells which gave
visible colonies after 3 to 4 days of growth on YPD plates. Each data point
corresponds to the mean of 3 independent experiments, and error bars
represent the standard deviation in Figure 14.

4.2.3. CAN1 forward mutation assay
Individual colonies were inoculated into 1 ml of YPD medium and grown
overnight with shaking at 250 rpm at 30oC to a density of 2 x 108 cells/ml.
Cells were washed once with sterile distilled water and then resuspended in 1
ml of sterile 50 mM potassium monohydrogen/dihydrogen phosphate buffer,
pH 7.0. For determination of Canr mutation rates, 100 µl of an appropriate
dilution (~100 cells) was plated on SD-arginine (SD-arg) medium and 200 µl
of the remaining culture (~4 x 107 cells) was plated on SD-arginine containing
canavanine (SD+can) medium. Plates were incubated for 5 days at 30°C, and
the number of Canr colonies was counted. Mutation rates were determined by
the method of the median (Lea and Coulson, 1948), and 95% confidence
intervals (CIs) were calculated as described in this reference. At least 10
independent cultures were used for all measurements of mutation rate.

4.2.4. MMS-induced mutagenesis
1 ml of cells was grown overnight in YPD medium, harvested and
resuspended in 1 ml of 50 mM potassium phosphate, pH 7.0. Methyl
methanesulfonate (MMS) was added to 0.1% and cells were incubated at
30°C with shaking for 40 min. An equal volume of 10% ice cold sodium
thiosulfate was added to the culture and incubated for 10 min. The cells were
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harvested, washed twice with sterile water and then suspended in 50 mM
potassium phosphate, pH 7.0. Cells were diluted and plated on SD plates
followed by the standard CAN1 mutation assay.

4.2.5. UV-induced mutagenesis
1 ml of cells was grown overnight in YPD medium, harvested and
resuspended in 1 ml of 50 mM potassium phosphate, pH 7.0. Cells were
diluted and plated on SD-arg and SD+can medium. The SD+can plates were
then exposed to UV light at a dose of 70% cell viability. All plates were
incubated for 5 days at 30°C, and the rest procedure followed the standard
CAN1 mutation assay.

4.2.6. Fluctuation analysis
To determine CAN1 mutation frequency, at least 10 independent cultures
were analyzed in each experiment and each experiment was repeated for at
least two times. The method of the median (Lea and Coulson, 1948) was
used to calculate CAN1 mutation rate and 95% confidence interval of each
rate.

4.2.7. Sequence analysis of CAN1 mutation spectra
Independent Canr colonies were isolated, and genomic DNA was
extracted with yeast DNA extraction kit (Pierce). CAN1 gene was amplified by
PCR and sequenced at UK Advanced Genetic Technologies Center.
Sequencing analysis was done using NCBI Blast request.
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4.3. Results
4.3.1. ynk1∆ strain displays a UV-induced mutator phenotype.
ynk1∆ strain didn’t display defects in growth rate, spore formation,
mating ability or morphology (Fukuchi et al., 1993). In our studies, ynk1∆
mutants exhibited no increase in spontaneous mutation rate than wild-type
strain from the described CAN1 forward mutation assay. Then both wild-type
and ynk1∆ strains were treated with DNA damaging agents MMS and UV
radiation. 0.1% MMS induced an 11-fold increase in mutation rate at CAN1
locus in ynk1∆ strain, compared to an 8-fold mutation increase in wild-type
strain (Figure 12A). However, the ratio of UV-induced mutation rate to
spontaneous mutation rate at CAN1 locus in ynk1∆ strain was 13:1, while
wild-type strain exhibited a 5-fold increase in UV-induced mutation rate. The
fold increase rate (13:5) between ynk1∆ and wild-type strains was significantly
different analyzed by one way ANOVA (Figure 12B). In addition, the UVinduced mutator phenotype was reproducible in ynk1∆ spore cells generated
from double mutants, in which the fold increase (UV-induced mutation
rate/spontaneous mutation rate) was consistently 2-3 fold higher than their
wild-type sporemates (data not shown). These results suggested that YNK1
deletion led to a moderate, but significant repair deficiency to UV-induced
DNA damage.

63

Figure 12. Deletion of YNK1 results in increased mutations in response
to MMS and UV insults. The CAN1 forward mutation rate was measured in
both wild-type and ynk1∆ strains under either spontaneous conditions or
following the treatment with DNA damaging agents MMS or UV. (A) 0.1%
MMS was used to induce CAN1 mutation rate. (B) A dose of 192 J/m2 of UV
radiation was used to induce CAN1 mutation rate. Both treatments resulted in
a 70% viability rate for both strains. 10 independent cultures were used for all
measurements and at least three experiments were performed, data was
analyzed by one way ANOVA.
A.

B.
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4.3.2. CAN1 mutation spectra analysis
CAN1 encodes an arginine permease (Ahmad and Bussey, 1986), and
any loss-of-function mutation at this locus confers resistance to canavanine.
To better understand the accumulation of mutations in the ynk1∆ strain, the
mutation spectra for both of wild-type and ynk1∆ strains was determined by
sequencing the CAN1 gene from approximately 20 independent Canr isolates.
As shown in Table 7, under basal conditions, the Canr mutations in wild-type
cells were base substitutions (59%) and deletions (23%), while ynk1∆ cells
had 70% of base substitutions and 6% of deletions. In UV-irradiated wild-type
cells the frequency of base substitutions was 53% and deletion 21%, which
resembled that of no treatment. The UV-irradiated ynk1∆ cells demonstrated
70% of base substitutions and 15% of frameshifts. Notably, the frameshift
events were only shown in this group. In addition, it’s interesting to note that a
frequency of thymidine (T) tract (at least three T in order) mutation alterations
in this group was as high as 65%, which was remarkably higher than any
other groups (e.g., 18% in wild-type cells with no treatment, 24% in ynk1∆
cells with no treatment and 26% in UV-irradiated wild-type cells).
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Table 7. CAN1 forward mutation spectrum
Genotype

Event

Wild type

Base substitution

Frameshift
Deletion

Complex

ynk1∆

Wild type
with UV
treatment

No mutation
Base substitution

Frameshift
Deletion
Complex
No mutation
Base substitution

Frameshift
Deletion

Complex

No mutation

Canr
Mutation
Frequency
G→T
2/17
G→A
4/17
T→G
1/17
C→A
1/17
C→T
1/17
T→C
1/17
Total
10/17(59%)
0/17(0%)
29 bp
2/17
~100 bp
1/17
~200 bp
1/17
Total
4/17(23%)
ACACCACAG→
1/17(6%)
CACAA
2/17(12%)
G→A
3/17
T→A
1/17
A→T
1/17
C→A
2/17
C→T
3/17
C→G
2/17
Total
12/17(70%)
0/17(0%)
~200 bp
1/17(6%)
0/17(0%)
4/17(24%)
G→A
2/19
G→T
3/19
T→C
3/19
C→A
1/19
C→G
1/19
Total
10/19(53%)
0/19(0%)
CGAA→C∆AA
1/19
TTTAT→TTT∆T
1/19
~150 bp
1/19
~350 bp
1/19
Total
4/19(21%)
AAATTA→TAATTT 1/19
CATTGCGCTC→
1/19
TATGCGCTT
Total
2/19(10%)
3/19(16%)
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ynk1∆
with UV
treatment

Base substitution

Frameshift

Deletion
Complex
No mutation

G→A
G→T
T→A
C→T
A→G
C→A
Total
T4→T2
T5→T6
T6→T7
Total
TTTTCTT→
TTTT∆TT
(TATTT)2→(T)11
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4/20
2/20
3/20
3/20
1/20
1/20
14/20(70%)
1/20
1/20
1/20
3/20(15%)
1/20(5%)
1/20(5%)
1/20(5%)

4.3.3. The double deletion between YNK1 and 9-1-1 component causes a
decrease in UV-induced mutagenesis.
Since redundancy of DNA repair mechanisms exist in cells, loss of one
gene function can be compensated by a separate pathway. At this point, to
study the possible interactions of YNK1 with other DNA repair mediators,
double knockout mutants were generated in ynk1∆ background, which
harbored a second deletion in a variety of known DNA checkpoints or DNA
repair genes (DDC1, RAD17, MEC3, RAD27 and MSH2). Ddc1p, Rad17p,
and Mec3p proteins form a heterotrimeric ring, with similar structure to
proliferating cell nuclear antigen (PCNA) in S. cerevisiae (Majka and Burgers,
2003; Thelen et al., 1999). Their human homologues are RAD9, RAD1, and
HUS1 respectively (9-1-1 complex). The 9-1-1 complex is a DNA damage
checkpoint and causes cell cycle arrest in response to DNA damage (Kondo
et al., 1999). Our microarray analysis has identified an elevated HUS1
expression in association with the loss of NM23 in metastatic cell lines.
The double mutant strain was generated by crossing a ynk1∆ mutant
with another knockout mutant (e.g. rad17∆) and four isogenic spores (e.g.
wild-type, ynk1∆, rad17∆ and ynk1∆ rad17∆) were isolated from a double
knockout diploid cell. The mutator phenotypes of the generated mutant cells
were analyzed by CAN1 forward mutation assay and compared with their
wild-type counterparts. Under spontaneous conditions, CAN1 mutation rates
of rad17∆, mec3∆ and ddc1∆ mutants exhibited 2.5-fold, 2.3-fold and 2.4-fold
respectively higher than the wild-type cell (Table 8), consistent with previous
study (Paulovich et al., 1998). As expected, the ynk1∆ rad17∆, ynk1∆ mec3∆
and ynk1∆ ddc1∆ double mutants displayed similar mutation rates as the
rad17∆, mec3∆ and ddc1∆ single mutants, since the deletion of YNK1 didn’t
affect the spontaneous mutation rate compared to wild-type cell (Table 8).
Meanwhile, the 9-1-1 single mutants and double mutants were treated with
UV radiation at different low doses according to their 70% UV viable rate.
Compare to UV-irradiated wild-type cells, UV-induced mutation rate of 9-1-1
single mutants was reduced by about 50%. The UV-induced mutation rate of
ynk1∆ ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆ double mutants was close to
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the ddc1∆, rad17∆ and mec3∆ single mutant, but 70-80% lower than the
ynk1∆ cell (Table 8).
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Table 8. Forward mutation rates at the CAN1 locus in wild-type and
mutant strains.
Strain
Wild type
ynk1∆
ddc1∆
ynk1∆ ddc1∆
rad17∆
ynk1∆ rad17∆
mec3∆
ynk1∆ mec3∆
rad27∆
ynk1∆ rad27∆
msh2∆
ynk1∆ msh2∆

Canr mutation rate per 107 cells (fold increase)
spontaneous
UV-induced
1.6 (1)
8 (1)
1.6 (1)
20 (2.5)
3.9 (2.4)
3.2 (0.4)
4.0 (2.5)
5.5 (0.7)
4.0 (2.5)
4.4 (0.6)
4.0 (2.5)
3.5 (0.4)
3.6 (2.3)
4.8 (0.6)
5.2 (3.3)
5.7 (0.7)
89 (56)
46 (5.8)
60 (38)
32 (4)
28 (18)
24 (3)
34 (21)
34 (4.3)

Mutation rates shown here are the averages of at least two independent
experimental sets. Fold increases in mutation rates compared to wild type are
indicated in parentheses.
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4.3.4. Deletion of YNK1 does not affect UV sensitivity of the ddc1∆,
rad17∆ or mec3∆ mutant.
UV sensitivity of the ynk1∆ ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆
double mutants was measured at gradient UV doses. As shown in Figure 13,
ynk1∆ mutants did not exhibit more sensitivity than wild-type strain. The
ddc1∆, rad17∆ or mec3∆ single mutants were very sensitive to the killing
effects of UV radiation, as previously reported (Longhese et al., 1997;
Paulovich et al., 1998). However, the deletion of YNK1 did not affect the UV
sensitivity of ddc1∆, rad17∆ and mec3∆ mutant in our studies.
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Figure 13. Deletion of YNK1 does not affect UV sensitivity of the wildtype cell and the 9-1-1 mutant. Cell viability was measured in wild-type,
ynk1∆, ddc1∆, rad17∆, mec3∆ and the corresponding double mutants,
following UV exposure at a gradient dose.
A.

B.

C.
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4.3.5. Characterization of the Canr mutations of the ynk1∆ rad27∆ and
ynk1∆ msh2∆ double mutants
S. cerevisiae RAD27 (homologue of human FEN1) proteins exhibited a
5’-3’ exonuclease activity and an endonuclease activity involved in DNA
replication and repair (Harrington and Lieber, 1994; Qiu et al., 2001). rad27
mutants displayed a strong spontaneous mutator phenotype and showed
increased rates of chromosome instability (Tishkoff et al., 1997). To examine
the relationship between YNK1 and RAD27, a ynk1 rad27 double knockout
mutant was constructed by crossing a ynk1∆ mutant to an isogenic rad27∆
mutant and dissecting tetrads from the resulting diploid. In comparison to the
wild-type cell, deletion of RAD27 caused a significantly greater increase in the
spontaneous Canr mutation rate (56-fold higher), which was consistent with
previous studies (Tishkoff et al., 1997). The mutation rate in ynk1∆ rad27∆
mutant was 30% lower than rad27∆ mutant. With UV dose of 70% viable rate,
the rad27∆ mutants had a 5.8-fold higher Canr mutation rate than the wildtype strain, while the ynk1∆ rad27∆ double mutants displayed a Canr mutation
rate (3.2 × 10-6) situated between ynk1∆ (2.0 × 10-6) and rad27∆ (4.6 × 10-6)
single mutants (Table 8).
The products of mismatch repair genes MSH2, MSH3 and MSH6 in S.
cerevisiae (MutS homologue of E. coli) form two complexes, Msh2p-Msh6p
complex and Msh2p-Msh3p complex (Kolodner, 1996; Marsischky et al.,
1996).

They

bind

and

function

in

the

repair

of

base-base

and

insertion/deletion mispairs, and reduce the accumulation of mutations during
DNA replication. To study the relationship between YNK1 and MSH2, a ynk1
msh2 double knockout mutant was constructed. Mutagenesis analysis
showed that msh2∆ mutants exhibited increased Canr mutations (18-fold
higher) than wild-type cells, consistent with previous reports (Lau et al., 2002).
The ynk1∆ msh2∆ double mutants showed a slight increase in spontaneous
mutation rate compared to msh2∆ single mutants. Following the UV treatment,
the msh2∆ mutants displayed a similar mutator phenotype as the ynk1∆
mutants (3-fold higher than wild-type), while the ynk1∆ msh2∆ double mutants
showed a small additive effect. The effects of the deletion of YNK1 and MSH2
on UV-induced mutagenesis seemed to be added (Table 8).
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4.4. Discussion
UV irradiation leads to DNA damage, primarily due to covalent linkage
between adjacent pyrimidines. Such photoproducts block the progression of
DNA polymerases and are potentially mutagenic. Nucleotide excision repair
proteins are recruited to the site of the lesion and repair the damage in an
error-free manner. This form of DNA repair reduces the mutation frequency
induced by UV irradiation. If the damage persists when the DNA is replicated
in S-phase of the cell cycle, translesion synthesis (TLS) is activated using an
error-prone mechanism that involves the non-processive DNA polymerase
zeta (Polζ) (McGregor, 1999). Polζ is consists of two subunits, catalytic
subunit REV3 and regulatory subunit REV7 (Nelson et al., 1996). Polζ is
required for the induction of mutations and Polζ mutants caused a decrease in
UV-induced mutagenesis. Recent studies demonstrated that the MEC3 and
DDC1 subunits of the 9-1-1 complex physically and functionally interacted
with the REV7 subunit of the Polζ, and the complex was required to stably
recruit Polζ onto damaged DNA (Sabbioneda et al., 2005). This evidence
provides an explanation for reduction in UV-induced mutagenesis in yeast 91-1 single mutants.
ynk1∆ strains displayed a significant UV-induced mutator phenotype that
was assessed by measuring resistance to the toxic arginine analog
canavanine, which suggests that YNK1 is likely to play an important role in
interacting with the UV damaged DNA. The Canr mutation spectrum indicates
that the mutations in the ynk1∆ strain primarily resulted from nucleotide misincorporation and frameshift events, which can increase the frequency of DNA
polymerase slippage, therefore enhancing the mutation rate. We suggest
three possible explanations for the DNA damage-dependent anti-mutator
function of YNK1: 1) YNK1 possibly functions as a redundant 3’-5’
exonuclease involved in DNA damage repair pathway; 2) YNK1 is likely to be
a redundant 3’-5’ exonuclease facilitating DNA polymerase fidelity; 3) the
NDPK activity of YNK1 maintains the intracellular nucleotide balance, as the
increased dCTP content has been suggested to result in the mutator
phenotype in ndk deficient E. coli strain (Lu et al., 1995).
Nucleotide excision repair (NER) is primarily implicated in repair of UVinduced DNA damage by an error-free manner. YNK1 could possibly be
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involved in the NER pathway by functioning as a redundant 3’-5’ exonuclease
to reduce mutations. The potential relationship of YNK1 and DNA damage
checkpoints (DDC1, RAD17, MEC3) or DNA repair enzymes (RAD27 and
MSH2) was probed by mutation rate measurements in a double knockout
strain. The effect of YNK1 in UV-induced mutagenesis is suppressed in ynk1∆
ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆ double mutants, suggesting that
YNK1 is not likely to be involved in the 9-1-1 clamp regulated pathway.
Rad27p, a structure-specific endo/exonuclease, plays an important role in
DNA replication through Okazaki fragment maturation and DNA repair of 5'blocked ends (Tishkoff et al., 1997). Based on the decrease in mutation rates
of ynk1∆ rad27∆ double mutants compared to rad27∆ single mutants, YNK1
does not seem to coordinately interact with RAD27. However, the majority of
Canr mutations in ynk1∆ strain are consistent with the mutation spectrum in
msh2∆ mutants, changing from single nucleotide mis-incorporations and
single/double-base frameshift events. Also, ynk1∆ msh2∆ mutants display a
small additive effect on the generation of mutations. This evidence suggests
that YNK1 is possibly involved in the mismatch repair pathway, exercising
mispaired bases as a redundant 3’-5’ exonuclease in response to DNA
damage.
The YNK1 amino acid sequence is highly homologous to NM23-H1,
which suggests that NM23-H1 could also function as an anti-mutator and play
an important role in mutations avoidance in humans, although direct evidence
about the impact of NM23 expression on mutation rate in mammalian cells is
lacking at present. Consistent with the putative DNA repair function of NM23H1 is our observation of accumulation of NM23 within subnuclear foci
following treatment with the DNA damaging agents etoposide, cisplatin and
UV radiation. Collectively, these lines of evidence strongly support our
hypothesis that NM23-H1 plays a critical role in maintaining genomic integrity
in the tumor cells, reducing the accumulation of mutations during tumor
metastasis pathway. Together, this study contributes to our understanding of
the mechanisms underlying the metastasis suppressor activity of NM23-H1.

Copyright © Mengmeng Yang 2008
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CHAPTER FIVE
GENERAL DISCUSSION

5.1. Conclusions and Discussion
Genetic instability results in a global increased mutation rate in a cell,
which is termed “mutator phenotype”. This idea was applied to carcinogenesis
in 1976 by Nowell, who suggested that genetically unstable cells produce
“successful” mutant clones for malignant process during tumor evolution
(Nowell, 1976). In other words, the accumulated genetic changes during
tumor progression might lead to an increasingly aggressive phenotype and
metastasis ultimately. Since the fidelity of DNA synthesis and DNA repair play
important roles in maintaining genomic integrity, loss of these functions
increase genomic instability and enhance cancer risk (Sieber et al., 2003). 3’5’ exonucleases have an essential role in DNA replication and DNA repair by
excising mismatched or modified nucleotides to maintain genomic integrity. At
least 11 human proteins have been reported to exhibit 3’-5’ exonuclease
activity, which are either associated with polymerase (for instance,
polymerases γ, δ and ε) or autonomous (such as, TREX1, TREX2, RAD1,
RAD9, MRE11, APE1, p53 and VDJP) (Shevelev and Hubscher, 2002).
Defects in the proofreading activity of the 3’-5’ exonucleases could cause
dramatic consequences in a cell. For instance, -1- a defective proofreading
function of an autonomous 3’-5’ exonuclease (dnaQ) in E. coli led to cell
inviability due to excessive error rates (Fijalkowska and Schaaper, 1996). -2A strong mutator phenotype in S. cerevisiae was induced owing to deficient
proofreading in combination with defective mismatch repair (Morrison et al.,
1993). -3- The loss of polymerase δ proofreading function can even lead to
cancer in mice (Goldsby et al., 2001). Taken together, these data indicate that
the 3’-5’ exonucleases play important roles in decreasing the mutation
frequency and possibly inhibiting the tumorgenicity and metastatic potential.
NM23-H1, the first metastasis suppressor, has been recently identified to
possess 3’-5’ exonuclease activity by our laboratory (Ma et al., 2004). NM23
proteins exhibit multiple enzymatic activities, consistent with its multiple
functions in many aspects of cell signaling. Currently, at least three distinct
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enzymatic activities of NM23-H1 are under active investigations for the
relevant mechanism underlying metastasis-suppressing effects of NM23-H1.
The 3’-5’ exonuclease activity of NM23-H1 represents a very plausible
candidate, as other well known 3’-5’ exonucleases are indeed implicated in
mechanisms of DNA repair. Moreover, the NDPK activity should also be
considered, in light of its potential role in maintaining balance in nucleotide
pool sizes. However, the histidine kinase activity of NM23-H1 might not be
relevant, since this apparent protein kinase activity could be an artifact
resulting from the presence of contaminating [γ-32P]ATP. The details will be
discussed later in this chapter.
Some evidence has been collected to suggest a role of NM23-H1 in DNA
repair. First, our laboratory has observed that nuclear translocation and
nuclear foci formation of NM23 proteins were responsive to DNA damaging
agents cisplatin and etoposide (Kaetzel et al., 2006). This is a typical
phenotype of DNA repair responses. Second, our laboratory has also
observed that multiple DNA repair genes (Rad51, HUS1, MLH1, BRCA1,
PCNA, FEN1, DNA polymerase θ and methyl-CpG binding protein) were
coordinately downregulated in two metastatic cell lines with NM23-H1
overexpression (Kaetzel et al., 2006). This observation reflects that genomic
instability is associated with the NM23-deficient state. Third, the mutator
phenotype in NDPK-null E. coli (Lu et al., 1995) provided a direct evidence for
a potential anti-mutator activity in a prokaryotic cell. Based on such evidence,
some important questions arose to us: Does the 3’-5’ exonuclease activity
mediate the metastasis suppressor activity of NM23-H1? If so, what specific
mechanism is involved? Is DNA repair activity involved in the anti-metastatic
function of NM23-H1? And, what kind of DNA repair pathway is regulated?
To address these important issues, a panel of NM23-H1 mutants with
selective enzymatic lesions have been constructed, characterized and
expressed in human melanoma cell lines. The transfected melanoma cells
have been conducted metastasis assays in vitro and in vivo. In addition, the
role of YNK1 (the yeast homologue of NM23) in DNA repair and maintenance
of genomic integrity has been assessed by measuring the impact of ablation
of the YNK1 gene on mutation rates in S. cerevisiae. Hopefully these studies
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will contribute to a further understanding of the anti-metastatic functions of
NM23-H1.

5.1.1. Site-directed mutagenesis identifies Glu5 and Lys12 are necessary
for the 3’-5’ exonuclease activity of the metastasis suppressor NM23-H1
To study the biochemical activity of NM23-H1 in metastasis suppression,
our laboratory initiated the site-directed mutagenesis assay of NM23-H1.
Previous results have shown that K12Q-H1 mutant lost both NDP kinase and
3’-5’ exonuclease activities, and H118F-H1 mutant only inhibited NDP kinase
activity (Ma et al., 2004). In this study, we demonstrated that both K12Q and
H118F mutants also disrupted the histidine kinase activity. In addition, to
completely develop a panel of NM23-H1 mutants for characterization of the 3’5’ exonuclease active site and identification of the relevant enzymatic
activities to the metastasis suppressor funciton, more residue substitutions of
NM23-H1 have been generated in this study. Previously, the K12Q mutant was
the only variant deficient in 3’-5’ exonuclease activity. In this study, we
identified that the E5A mutant also significantly disrupted the 3’-5’
exonuclease activity of wild-type-H1 without markedly affecting other
enzymatic activities. As the only variant selectively deficient in the
exonuclease activity, E5A has the potential to provide insights into this
enzymatic activity in DNA repair. Although both Glu5 and Lys12 are required for
the 3’-5’ exonuclease activity of NM23-H1, whether they might be coordinate
for the enzymatic activity is not known yet. However, they are at opposite
ends of β1 sheet, suggesting that the β1 sheet of NM23-H1 is important in
binding and cleaving DNA substrate.

5.1.2. The histidine kinase activity of NM23-H1 might be artifactual
In the histidine protein kinase assay (performed by Robert McCorkle),
NM23-H1 proteins were autophosphorylated at the residue His118 by
incubation with [γ-32P]ATP, and the unbound ATP was diluted and rinsed off
by successive rounds of ultrafiltration. Then the phosphorylated NM23-H1
was subsequently incubated with NM23-H2, the target protein of this assay.
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The

phospho-NM23-H2

was

visualized

by

gel

electrophoresis

and

phosphorimaging. A coordinate reduction in both NDPK and hisK activities
was shown among all of the mutants K12Q, Y52A, P96S, and H118F. This is
difficult to explain, as the binding pockets for such disparate kinase substrates
(nucleoside diphosphates versus proteins) should be quite different. An
alternative explanation posed by Postel (Levit et al., 2002) is that the apparent
protein kinase activity of NM23-H1 may be an artifact resulting from the
presence of trace amounts of [γ-32P]ATP in the reaction mixtures. This
contaminating [γ-32P]ATP could come from the produced ADP that is recycled
by the nucleoside diphosphate kinase reaction. Thus, phosphorylation of the
target protein (NM23-H2) is not a result of direct phosphotransfer from the
phospho-NM23-H1 but rather a consequence of generation of [γ-32P]ATP from
the produced ADP. Since nanomolar concentrations of contaminating ADP
can

trigger

the

phosphotransfer

cascade

(Levit

et al., 2002), the

contaminating ATP is not easily detected. In this experiment, the unbound
ATP represents less than 5% of that bound to NM23-H1. The contaminating
ATP may function more as a catalyst in this phosphotransfer cascade than a
donor supplying the phosphoryl groups. Since this histidine kinase assay was
conducted in parallel with the metastasis assay, we did not realize this
possibility at the time we performed the metastasis assay. However, this
finding indicates that the previously proposed role of the histidine kinase
activity in mediating the metastasis suppressor activity of NM23-H1
(Hartsough et al., 2002) may need to be reexamined.
5.1.3. 3’-5’ exonuclease activity of NM23-H1 is necessary to suppress in
vivo spontaneous metastasis
To identify the relevant enzymatic activity to the metastasis suppression
of NM23-H1, our laboratory has initiated the lung metastasis assay using
1205Lu cells stably transfected with NM23-H1 in nude mice. 1205Lu
melanoma cells are suitable for this experiment due to its characteristics of
high malignance with low background of NM23 expression. The spontaneous
metastasis assay recapitulates most of the steps of cancer metastasis from
primary tumor formation to metastatic lesion, representing the most powerful
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model for studying metastasis. In the spontaneous metastasis assay, NM23H1

transfected

melanoma

cells

were

subcutaneously

injected

into

experimental mice. After the primary tumors were removed, mice were
continually raised for another 3 months to form lung metastases.
Although 1205Lu cells are highly malignant, the spontaneous lung
metastases still need long time (3 months) to complete. Since the cells are
human-derived, they need acquire some genetic changes to adapt to their
new mouse environment after they are injected subcutaneously. In this study,
we observed that the wild-type NM23-H1 significantly inhibit the spontaneous
lung metastasis of 1205Lu melanoma cells without affecting the growth of
primary tumor. In the primary tumors of 1205Lu cells, genomic instability is
associated with NM23-deficient stage. In light of our microarray data, some
DNA repair genes such as Rad51, HUS1, MLH1, BRCA1 and FEN1 might be
upregulated at H1-deficient primary sites. The DNA repair-like activity of
NM23-H1 might oppose the genetic instability of the 1205Lu cells, thereby
decreasing their spontaneous metastatic potential. Also it is recently reported
that some genes involved in motility and anchorage independent growth
(EDG2) are downregulated by NM23-H1 (Horak et al., 2007), supporting a
role of NM23-H1 in suppressing early stage of metastasis. In the experimental
metastasis models, since large numbers of 1205Lu cells are introduced
directly into the vein, the cells have omitted the early rate-limiting steps of
metastasis. Therefore, the metastasis-suppressing effect of NM23 is absent in
the tail-vein injected mice. These results indicate that NM23-H1 may exert the
suppressive effects on the earlier steps of metastases by inhibiting genomic
instability at the primary sites.
In this study, site-directed mutageneses of NM23-H1 (E5A-H1 and
K12Q-H1) demonstrate that 3’-5’ exonuclease activity is necessary to suppress
the spontaneous metastatic potential of 1205Lu melanoma cells. Originally,
we hypothesized that the histidine kinase activity was not required for the
metastasis suppressor function of NM23-H1 since the hisK-deficient mutation
(P96S) still maintained a significant anti-metastatic capacity. However, as
discussed above, we gradually realized that the histidine kinase activity of
NM23-H1 might be artifactual. The reason for why P96S-H1 did not lose the
metastasis-suppressing function is that P96S-H1 still possesses significant 3’80

5’ exonuclease activity. This further supports the necessities of the 3’-5’
exonuclease activity for metastasis suppressor function of NM23-H1.
Interestingly, similar to the pattern observed in the metastasis assay,
K12Q but not P96S mutant lost the effects of anti-metastatic progression
exhibited by wild-type-H1 (Qingbei Zhang, Ph.D. dissertation 2006). This
evidence further indicates that 3’-5’ exonuclease activity is required to
suppress the metastatic progression of melanoma cells. The effects of E5A on
the anti-metastatic progression would address the relevance of the 3’-5’
exonuclease activity further, while the investigation (performed by Marián
Novak) is currently underway.

5.1.4. The metastasis suppressor NM23-H1 is required for DNA repair
As known 3'-5' exonucleases are generally required for maintenance of
genomic integrity, DNA repair activity represents a logical cellular function for
the nuclease activities of NM23-H1 and NM23-H2. A previous study in E. coli
provided an early indication that the NM23 homologue, ndk, was required for
maintaining genomic integrity (Lu et al., 1995). However, the exact enzymatic
activity(s) of ndk required for antimutator activity was not identified directly in
that study. To measure the contribution of NM23-H1 to DNA repair, we have
initiated experiments in the yeast Saccharomyces cerevisiae. The wellrecognized characterizations of DNA repair pathways and mechanisms in
yeast cell provide it an excellent genetic model to determine the role of NM23
proteins in DNA repair.
In this study, we have examined the contributions of YNK1, the yeast
NM23 homologue, to genomic integrity in S. cerevisiae. Mutation rates were
measured in a haploid YNK1 knockout (ynk1∆) strain using the standard
CAN1 forward mutation assay. Disruption of the YNK1 gene in a haploid
strain had no effect on viability, growth rate, spore formation, mating ability
and morphology (Fukuchi et al., 1993). In this study, although the YNK1
deletion had no effect on spontaneous mutation rate relative to wild-type,
significantly increased mutations were observed in the ynk1∆ strain following
treatment with UV radiation. These results suggest that YNK1 deletion leads
to a significant repair deficiency to UV-induced DNA damage. Mutation
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spectra demonstrate the most UV-induced mutations in ynk1∆ strain are base
substitutions and frameshifts. The high conservation between YNK1 and
NM23-H1 further indicates an anti-mutator function for the human homologue.
The possible pathways could be: NM23 is directly involved in the repair
process by recognizing, binding and excising modified or mutant DNA; NM23
interacts with other DNA repair mediators; NM23 regulates other gene
expressions which are required for maintaining genomic integrity.
To identify possible interactions of YNK1 with other DNA repair
mediators, additional lesions were introduced into a variety of known DNA
checkpoints and DNA repair genes (DDC1, RAD17, MEC3, RAD27 and
MSH2) in the ynk1∆ background. The ability of YNK1 to oppose UV-induced
mutagenesis was negated in ynk1∆ ddc1∆, ynk1∆ rad17∆ and ynk1∆ mec3∆
double mutants, suggesting YNK1 is not likely to be involved in the 9-1-1
clamp-regulated pathway. However, the ynk1∆ msh2∆ strain exhibited an
additive effect of the two deletions on UV-induced mutation rate, with a
mutational spectrum of nucleotide misincorporations and single/double-base
frameshifts events in the msh2∆ strain consistent with that of ynk1∆. Taken
together, these observations suggest involvement of YNK1 in mismatch repair
processes.
There are some DNA repair pathways that NM23 protein might be
involved: 1) Based on the formation of a Schiff-base intermediate in NM23-H2,
the residue Lys12 of NM23-H2 has been indicated to play a DNA
glycosylase/lyase-like role (Postel et al., 2000). The Lys12 is a highly
conserved residue, which is necessary for both NM23-H1 and NM23-H2 in
their DNA cleavage activity. Since DNA glycosylase activity is a signature of
base excision repair (BER), NM23 may play a role in BER in which the εamino group of lysine acts as a critical nucleophile in DNA cleavage reaction
(Nash et al., 1997). 2) NM23 might be involved in mismatch repair pathway,
since the deletion of YNK1 and MSH2 cause an additive phenotype of
mutations following treatments of UV radiation with same mutational spectrum.
3) Upon the evidence that UV insult induces nuclear translocation and nuclear
foci formation of NM23 proteins (Kaetzel et al., 2006), and that yeast cells
lacking functional YNK1 exhibits defective repair of UV damage, NM23 might
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play a role in repairing UV-damaged DNA in nucleotide excision repair
pathway.
In a summary, evidence is accumulating across a wide range of
prokaryotic and eukaryotic organisms in support of a role for NM23-H1 in
maintaining genomic integrity. Since NM23-H1 possesses multiple enzymatic
activities, the mechanisms of action could be: 1) the 3’-5’ exonuclease activity
may play an important role in DNA repair, especially under genotoxic stress. 2)
The 3’-5’ exonuclease activity might excise a misincorporated nucleotide
during DNA replication. 3) The NDPK activity maintains nucleotides balance,
which might facilitate the fidelity of DNA polymerase by providing balanced
nucleotides. Therefore, during tumor evolution, NM23 is necessary to reduce
the generation and accumulation of mutations, by which it may inhibit cancer
cells to acquire more genetic instability for metastatic development.
The eventual aim of this study is to utilize the metastasis suppressor
NM23-H1 in the clinical setting as new therapeutic targets. To this end, our
understandings that DNA repair activity of NM23-H1 is involved in its antimetastatic mechanisms may contribute to new drug discoveries. For instance,
metastasis may be suppressed or delayed by restoring the expression of
NM23-H1, especially its 3’-5’ exonuclease activity. The increased levels of
DNA repair would result in a decrease in the accruement of mutations during
metastasis progression, thereby reducing the metastasis incidence.

5.2. Future Perspectives

5.2.1. To measure the impact of NM23-H1 expression on mutation rates
in mammalian cells.
The mutation rate is increased in Ndk-null E. coli and ynk1∆ S.
cerevisiae strains, suggesting genes Ndk and YNK1 (NM23 homologues) play
important roles in opposing mutations. The yeast experimental paradigm of
this project needs to be performed on NM23-deficient mammalian cells to test
the role of NM23 as a guardian of genome integrity in mammalian cells.
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Mouse embryo fibroblasts (MEFs) from NM23-M1 knockout mice are available
in our lab. So, firstly, mutation rates at the hypoxanthine phosphribosyltransferase (hprt) locus will be compared between MEFs derived from wildtype and NM23-M1 knockout mice under basal conditions. Toxic nucleoside
analog 6-thioguanine (6-TG) will be used to select hprt mutant cell. Cells
without the hprt mutation are poisoned by 6-TG, while mutant cells survive
and form colonies. A known numbers of cells will be seeded in medium
containing 6-TG to detect mutant cells, and medium without 6-TG can be
used to obtain a plating efficiency. Mutant frequency is derived from the
number of mutant colonies in selective medium and the number of colonies in
non-selective medium (Glaab and Tindall, 1997). Mutation rates will also be
compared under conditions of genotoxic stress. Etoposide and UV radiation
can be firstly chosen to treat MEFs, since we have observed that -1- these
two treatments induced translocation of NM23 proteins to subnuclear foci. -2YNK1 played an important role in UV damaged DNA response. There
evidences suggest that genomic integrity would be compromised following
treatment of UV radiation in NM23 deficient cells. Secondly, the degree of
correlation between NM23-H1 status and mutation rate need to be determined
in human melanoma cell lines. 1205Lu melanoma cells need to be examined
due to the high malignancy and NM23 low background of the cells. The
mutation rates can be measured under basal condition and genotoxic insult at
the hprt locus, as described above. Or to circumvent the polyploidy of hprt
gene, the mutation rates of 1205Lu cells can be also measured at Na+/K+
ATPase locus for ouabain resistant (OuaR) mutations, as described previously
(Elmore and Barrett, 1982). Thirdly, to identify the relevant biochemical
activity of NM23-H1 mediating its anti-mutation function, mutator phenotype of
NM23-M1 knockout MEFs and 1205Lu cells will be complemented with wildtype or mutant (E5A, K12Q, P96S and H118F) NM23-H1. The complementary
effects with NM23 variants will be related to their specific activities (NDPK
and/or 3’-5’ exonuclease).
5.2.2. To measure the extent to which deletion of YNK1 affects a
mismatch repair
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To directly assess whether an ablation of YNK1 causes a defect in
mismatch repair (MMR), wild-type, ynk1∆, msh2∆ and ynk1∆ msh2∆ strains
will be transformed with an A:C mismatch-containing plasmid. Since the A:C
mismatch resides in an ADE8 gene, ADE8 genes in the aforementioned
strains need to be inactivated as previously described (Tishkoff et al., 1997)
before plasmid transformation. The plasmid carries a functional URA3 gene,
so the transformants can be selected on SC-uracil plates. If the mismatch is
corrected prior to DNA replication, the resulting colony is nonsectored and
either red or white. However, if the mismatch is not repaired, then the two
ADE8 alleles segregate after DNA replication, resulting in a red/white
sectored colony. The proportion of sectored colonies will positively reflect an
extent of MMR defect. In the wild-type strain, only a small number of plasmids
escape repair, yielding sectored colonies. The msh2 mutant will be expected
to yield about 60% of sectored colonies as previous described (Chen et al.,
1999; Luhr et al., 1998). The impacts of the disruption of YNK1 on MMR and
the potentiating effects to MSH2 gene will be reflected by the proportion of
red/white sectored colonies in ynk1∆ and ynk1∆ msh2∆ strains respectively.
This approach effectively examines the impacts of ynk1 mutant on MMR
defects in vivo.

Copyright © Mengmeng Yang 2008
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